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Stellingen 
1. De seizoensinvloed op de bloeddruk is onmiskenbaar. In de zomer is de bloeddruk lager 
dan in de winter. 
Dit proefschrift 
2. Aangezien de bloeddrukverlagende effecten van medicamenteuze en niet-
medicamenteuze behandelingen vergelijkbaar zijn, verdient de niet-medicamenteuze 
behandeling meer aandacht vooral met het oog op kosten en neveneffecten. 
Dit proefschrift 
3. In observationeel onderzoek kunnen de afzonderlijke associaties van de inname van 
kalium, magnesium en calcium met de bloeddruk niet betrouwbaar bepaald worden 
vanwege sterke onderlinge correlaties. Gebruik van bijvoorbeeld de residu methode kan 
wel leiden tot andere correlaties, maar de betrouwbaarheid van de associaties verandert 
daardoor niet. 
4. Het eten van groente en fruit heeft behalve een beschermend effect op kanker ook een 
bloeddrukverlagende werking. 
NRC Handelsblad, 5 oktober 1994; dit proefschrift 
5. Een uitspraak over lange-termijn trends in bloeddruk kan alleen worden gebaseerd op 
continue bloeddrukmetingen over een zeer lange periode en niet op incidentele bloeddruk-
metingen met intervallen van 5 tot 10 jaar. 
6. Het drinken van een paar glazen alcoholische drank per dag heeft een positief effect op 
hart- en vaatziekten. Het negatieve effect op de bloeddruk dient hierbij in ogenschouw te 
worden genomen, met name voor rokers. 
7. Meer gedegen onderzoek is nodig voordat lichamelijke inactiviteit als determinant van 
hoge bloeddruk erkend kan worden. 
World Hypertension League, Physical exercise in the management of hypertension, Bull 
WHO 1991;69:149-153. 
8. Naarmate rapporten zijn opgesteld door meer gerenommeerde personen of instanties 
verdient het sterker aanbeveling de literatuur waarop deze uitspraken gebaseerd zijn, 
kritisch te evalueren. 
Joint National Committee on Detection, Evaluation, and treatment of high blood pressure, 
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment 
of high blood pressure (JNC V), Arch Intern Med 1993;153:154-183. 
9. De vanzelfsprekendheid waarmee het overleven van de mens centraal staat in toekomst-
scenario's staat in schril contrast met de massale uitstervingsgolf in planten- en 
dierenwereld die de mens veroorzaakt heeft. 
10. Het ageren tegen vriendjespolitiek klinkt vreemd in het licht van de huidige tendens 
om 'networking' te stimuleren. 
Stellingen behorend bij het proefschrift "Blood pressure: trends, determinants and 
consequences" van Edith van Leer 
Wageningen, 14 juni 1995 
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ABSTRACT 
BLOOD PRESSURE: TRENDS, DETERMINANTS AND CONSEQUENCES 
PhD Thesis. 
Agricultural University, Wageningen, The Netherlands and the National Institute of Public 
Health and Environmental Protection, Bilthoven, The Netherlands. 
Edith M. van Leer 
Trends in blood pressure, prevalence and treatment of hypertension were studied in 
30,000 men and women aged 37-43 years during the period 1974-1980, in 80,000 men 
aged 33-37 years during the period 1981-1986 and 36,000 in men and women aged 20-59 
years during the period 1987-1991. Between 1974 and 1991 changes in systolic and 
diastolic blood pressure were minor with the exception of an increase in the prevalence of 
hypertension in men between 1974-1980. Between 1981 and 1991 the prevalence of 
hypertension remained stable in men and in women between 1987 and 1991. More women 
than men were treated for hypertension; this did not change between 1974 and 1991. An 
increase in the percentage of treated hypertensive men between 1974 and 1986 was 
followed by a decrease in the period between 1987 and 1991 when a decrease in the 
treatment of hypertension in women was also seen. 
In a cross-sectional analysis in about 30,000 men and women aged 20-59 years a 
linear relation between alcohol consumption and blood pressure was observed in men. The 
results in women suggest a threshold of two glasses per day. In this study it was observed 
that gender, age and smoking were important effect modifiers of the alcohol-blood 
pressure association. An inverse association was observed between blood pressure and the 
intake of potassium and magnesium in both men and women. Dietary calcium was 
inversely related to systolic blood pressure in women and to systolic and diastolic blood 
pressure in both men and women. Men and women consuming a diet high in potassium, 
magnesium and calcium had about 2 mmHg lower blood pressure than their counterparts 
consuming a diet low in these minerals. 
In a 12-year follow-up study in 50,000 men and women aged 30-54 at baseline, 
elevated blood pressure was strongly related to cardiovascular and total mortality in both 
sexes. However, in men the mortality rates and relative risks were higher than in women. 
It was estimated that a reduction of 6 mmHg in diastolic blood pressure results in a 41% 
reduction in cardiovascular mortality and 28% reduction in total mortality for men and 
29% and 12%, respectively, for women. Evidence from observational studies and 
intervention trials suggest that such a reduction may be achieved through preventive 
measures such as weight control, alcohol and salt restriction, and increased potassium 
intake. 
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GENERAL INTRODUCTION 
Coronary heart disease (CHD) and cerebrovascular accidents (CVA) are the 
main causes of death in the Netherlands (1). Of the 129,000 people who died 
in 1990, 17% were victems of coronary heart disease and 10% of cerebro-
vascular accident. High blood pressure, together with smoking and elevated 
serum cholesterol is one of the major risk factors for cardiovascular diseases 
(CVD) and the most important one for cerebrovascular accidents (2). It has been 
calculated that 25% of the coronary heart disease and cerebrovascular accident 
mortality in the Netherlands can be attributed to high blood pressure (3). 
The risk associated with raised blood pressure increases progressively 
through the entire range of blood pressure levels and the dividing line between 
'normotension' and 'hypertension' is arbitrary. The most commonly used 
definition of hypertension is the one proposed by the WHO: i.e. persons with a 
systolic blood pressure of >160 mmHg and/or a diastolic blood pressure of >95 
mmHg and/or use of antihypertensive medication are called hypertensive (4). 
Because this also includes persons who actually are hypertensive but whose 
blood pressure is controlled by medication, this is a practical definition to 
estimate the prevalence of hypertension in a population. Hypertension is divided 
in primary and secondary hypertension (5). Essential hypertensives are defined 
as individuals who may have generalized or functional abnormalities causing 
their hypertension. Individuals with a specific organ defect responsible for 
hypertension are called secondary hypertensives. Of all patients with 
hypertension, 90-95% have essential hypertension (6). 
The measurement of intra-arterial blood pressure is the 'gold standard'. 
For practical purposes blood pressure is measured with a mercury sphygmo-
manometer using the Korotkoff sound technique (7). In practice, the difference 
between the intra-arterial blood pressure measurement and the measurement with 
the sphygmomanometer is small unless the arm circumferences are smaller or 
larger than appropriate for the standard cuff-size (8). Under standardized 
conditions the reproducibility of the blood pressure measurement is reasonably 
good. The correlation coefficients for repeated systolic and diastolic blood 
pressure measurements are generally in the order of 0.7 (9,10). 
Blood pressure can be influenced by several factors such as age, diabetes 
mellitus; alcohol consumption; intake of sodium, potassium, calcium and 
magnesium; obesity and physical activity (11,12). The modifiable lifestyle 
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factors such as alcohol consumption, mineral intake and obesity are of great 
importance for primary prevention and form a part of the treatment of hyper-
tension. 
High blood pressure is one of the major risk factor for cardiovascular 
diseases. The level of blood pressure in the population is directly related to the 
burden of cardiovascular diseases in the society. From a public health 
perspective data are needed on levels and trends in blood pressure, and on the 
prevalence and treatment of hypertension in the population. For primary 
prevention purposes information is needed about the relationship between 
lifestyle-related risk factors and blood pressure. 
The studies described in this thesis are given in Table 1. The first 
screening project (the Consultation Bureau Heart Project or CB Heart Project) 
was carried out between 1974 and 1980. In this period about 30,000 men and 
women with an average age of 40 years were examined. The second screening 
project (the Coronary Heart Disease Risk Factor Project or RTFOH Project) was 
carried out between 1981 and 1986. This study included about 80,000 men with 
an average age of 35 years. The aim of these studies was both to screen a large 
number of people and to give persons in a high-risk category advice about risk 
factor reduction. In Chapter 2 the baseline data from the CB Heart and RIFOH 
Projects were used to study the trends in systolic and diastolic blood pressure, 
as well as the prevalence and treatment of hypertension. 
The Cardiovascular Risk Factors Monitoring Project (CRFM Project) was 
carried out between 1987 and 1991. In that period about 36,000 men and women 
aged 20-59 years were examined. In Chapter 3 data from the CRFM Project 
were used to study levels and trends in systolic and diastolic blood pressure and 
prevalence, and treatment of hypertension in men and women. In this chapter 
we also described seasonal variation in blood pressure. 
Data of the CRFM Project were used in Chapter 4 to describe the form 
of association between alcohol consumption and blood pressure. Furthermore, 
effect modification and confounding of this association by age, smoking, degree 
of obesity, coffee consumption, physical activity during leisure time and 
educational level were studied. Data from this project were also used to 
investigate the association between blood pressure and the intake of dietary 
potassium, magnesium and calcium (Chapter 5). High correlations between the 
different dietary minerals called for assessment of the combined effect of 
potassium, magnesium and calcium intake on blood pressure. 
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Table 1. Description of the three studies used in this thesis 
Project Period Number Gender Age Aim of the study 
Consultation Bureau Heart Project 
(CB Heart) 
1974-1980 30,000 men 
women 
37-4-3 trends in blood pressure, and prevalence and 
treatment of hypertension (chapter 2) 
Coronary Heart Disease Risk 
Factor Project (REFOH) 
1981-1986 80,000 men 33-37 trends in blood pressure, and prevalence and 
treatment of hypertension (chapter 2) 
Cardiovascular Risk Factors 
Monitoring Project (CRFM) 
1987-1991 36,000 men 
women 
20-59 1 trends in blood pressure, and prevalence and 
treatment of hypertension (chapter 3) 
2 association between alcohol consumption and 
blood pressure (chapter 4) 1 
3 association between the intake of potassium, 
magnesium and calcium, and blood pressure 
(chapter 5) 
Consultation Bureau Heart Project 
(CB Heart)2 
1974-1980 50,000 men 
women 
30-54 association between blood pressure and 
mortality from coronary heart disease, 
cerebrovascular disease, cardiovascular disease 
and all causes (chapter 6) 
1 This association was studied in 30,000 men and women and the data was collected between 1987-1990. 
2 This is the same project as used for the trend analysis, but instead of only subjects aged 37-43 years the total study population was used. 
Chapter 1 
In Chapter 6 we used the data from the Consultation Bureau Heart Project 
carried out between 1974 and 1980. In this period about 50,000 men and women 
aged 30-54 years were screened. Between 1987 and 1993 the vital status of all 
these persons was verified; of those who died the underlying causes of death 
were established. The association between blood pressure, hypertension and 
mortality from coronary heart disease, cerebrovascular accident, cardiovascular 
diseases and all causes was studied. Particularly investigated were possible 
differences in the form and strength of the association between men and women, 
as well as effect modification by smoking status and obesity. Further to this, the 
population-attributable risks were calculated for different degrees of 
hypertension. 
In Chapter 7 we discussed the methodological problems in trend studies 
and investigated whether these problems were specific for our studies or could 
also be observed in those conducted in other countries. The results on the life-
style-related determinants of blood pressure are discussed in the context of those 
of other important observational studies and intervention trials. Also, the 
importance of modifiable lifestyle factors not investigated in this thesis is 
discussed. Finally, primary prevention and non-pharmacological treatment of 
hypertension are discussed in the context of guidelines for management of 
hypertension. 
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TRENDS IN BLOOD PRESSURE AND PREVALENCE AND 
TREATMENT OF HYPERTENSION IN YOUNG ADULTS IN 
THE NETHERLANDS, 1974-1986 
ABSTRACT 
Data from two screening projects on cardiovascular risk factors were used to investigate 
trends in blood pressure and the prevalence and treatment of hypertension in the Netherlands 
between 1974 and 1986. Between 1974 and 1980 about 30,000 men and women aged 37-13 
were screened. Between 1981-1986 about 80,000 men aged 33-37 were examined. An increase 
of 2 mmHg in average systolic blood pressure in men in the period 1974-1980 was followed 
by an insignificant change during the period 1981-1986. Average diastolic blood pressure 
increased by 4 mmHg between 1974 and 1980, but decreased by the same amount between 
1981 and 1986. The prevalence of hypertension in 40-year-old men increased from 12.7% in 
1974 to 17.8% in 1980. The prevalence of hypertension in 35-year-old men did not change 
between 1981 and 1986 and amounted to 9.6%. Treatment of 40-year-old hypertensive men 
increased from 8% in 1974 to 21% in 1980 and from 9% in 1981 to 13% in 1986 among 35-
year-old men. Average systolic blood pressure did not change in 40-year-old women between 
1974-1980 but average diastolic blood pressure increased by 2 mmHg during that period. The 
percentage of hypertensive women was 8.5% and did not change between 1974 and 1980. 
Also, the percentage of treated hypertensive women did not change and amounted to 28%. 
It can be concluded that the prevalence of hypertension did not change in 40-year-old women 
while in 40-year-old men it increased between 1974-1980. In 35-year-old men the prevalence 
of hypertension did not change between 1981-1986. Treatment of hypertension was more 
common in young adult women than in young adult men. However, an increase in treatment 
of hypertension in young adult men was observed in both periods. 
Edith M. van Leer, W. M. Monique Verschuren, Daan Kromhout 
European Journal of Epidemiology 1994,10; 151-158. 
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Trends in blood pressure, 1974-1986 
INTRODUCTION 
Blood pressure is considered a major risk factor for cardiovascular diseases 
(CVD) (1-3). In the Netherlands no information is available about trends in 
blood pressure. From a public health point of view it is of interest to investigate 
changes in systolic and diastolic blood pressure levels as well as the prevalence 
and treatment of hypertension. Between 1974 and 1986 two screening projects 
on cardiovascular risk factors were carried out in The Netherlands. During the 
total study period blood pressure was measured in a standardized way. With data 
from these two projects, the trends in blood pressure as well as the prevalence 
and treatment of hypertension in 40-year-old men and women during the period 
1974-1980 and in 35-year-old men during the period 1981-1986 were studied. 
METHODS 
The Consultation Bureau Heart Project (CB Heart Project; 1974-1980) and the 
Coronary Heart Disease Risk Factor Project (the PJFOH Project; 1981-1986) 
were carried out by tuberculosis clinics or 'Consultation Bureaus' in Amsterdam, 
Doetinchem, Maastricht, Tilburg and Leiden. These towns are located in 
different parts of The Netherlands: Amsterdam, the capital city (700,000 
inhabitants) and Leiden (100,000 inhabitants) are situated in the west; 
Doetinchem (40,000) is a small town in a rural area in the east; Maastricht 
(100,000) lies in the south, and Tilburg (150,000) is a middle-sized industrial 
town in the southwest. 
The CB Heart Project was initiated in October 1974 in Tilburg and 
Doetinchem. In 1976 consultation bureaus in Amsterdam, Maastricht and Leiden 
joined the study. For the CB Heart Project different birth cohorts were selected 
in different towns. All persons born in certain years were invited for the study. 
Names and addresses of the participants were obtained from the municipal 
registry. The response rate, about 80% at the beginning of the study, dropped 
to about 70% at the end of the study (4). During the period 1974-1980 a total 
of about 50,000 men and women, who varied in age between 30 and 54 years, 
were examined. The age range differed from town to town. Therefore, a 
subsample with a narrower age range (37-43 years) was selected for the trend 
analyses. The mean age of those 30,000 persons was 40 years. In Leiden, the 
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age range of the subjects examined in the period 1974-1980 deviated and 
therefore data from Leiden were excluded from the trend analyses for this 
period. 
In 1981 the CB Heart Project was followed by the RIFOH Project. This 
project covered only men aged 33-37 years (about 80,000 in total) in the 5 
towns. Potential respondents were identified from the civil registry and invited 
to participate. For each 2-year period, certain birth cohorts were invited to 
participate: from 1981 to 1982, all men born in 1946 and 1947; from 1983 to 
1984, all men born in 1948 and 1949; and from 1985 to 1986, all men born in 
1950 and 1951. This ensured a narrow age range across the entire study period, 
and no respondents had to be excluded in the trend analyses. The response rate 
was on the average about 55% for Amsterdam and about 70% for the other 
towns. The mean age of the subjects participating in the RIFOH Project was 35 
years during the whole study period (1981-1986). 
In both the CB Heart Project and the RIFOH Project, information was 
obtained on risk factors for coronary heart disease using standardized methods 
(4). The participants filled out a questionnaire in which information was 
obtained about smoking habits, current use of medication for high blood 
pressure, history of hypertension, diabetes and complaints of cardiovascular 
disease. Blood was taken for total cholesterol determination. Height, weight and 
blood pressure were measured. Blood pressure was measured once in the sitting 
position with a random zero sphygmomanometer. The measurements were 
carried out by the same trained technicians in both projects. The technicians had 
received detailed instructions on use of the sphygmomanometer (5). The cuff 
(size 12 x 23 cm) was applied to the left upper arm. Systolic blood pressure was 
recorded at the appearance of sounds (first-phase Korotkoff) and the diastolic 
blood pressure was recorded at the disappearance of sounds (fifth-phase 
Korotkoff). Hypertension was defined according to the criteria of a WHO expert 
committee as a systolic blood pressure >160 mmHg and/or a diastolic blood 
pressure >95 mmHg and/or use of antihypertensive medication (1). 
For statistical analyses the SPSS/PC+ package program was used (6). 
Multiple linear regression analysis was performed for trend analyses using blood 
pressure or percentage hypertensives or percentage on medication as the 
dependent variable and time (months) as the independent variable. Adjustment 
for age differences was made by calculating the regression coefficients for the 
relation between age and the dependent variables. Subsequently, the dependent 
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variable for each individual was extrapolated to a value for a subject 40 years 
of age (CB Heart Project) or 35 years of age (RIFOH Project). The age-adjusted 
blood pressure or percentage hypertensives or percentage on medication was 
then used as the dependent variable in the regression analysis. Age-adjustments 
for hypertension and treatment of hypertensives were made by analysis of 
covariance. Analysis of variance was used to investigate regional differences in 
blood pressure level. Contrasts were tested for statistical significance using the 
Scheffe test. 
During the study period the number of persons per town differed. An 
increasing number of persons from a town with a high (or low) blood pressure 
could cause an artificial time trend. Therefore, dummy variables for the different 
towns were added to the regression model, using Amsterdam as a reference. As 
a rule the overall regression coefficients are presented. Only in case of a 
difference in the trends in mean blood pressure between the various towns, are 
these differences specified. 
In the RIFOH Project the average systolic blood pressure first increased 
and then decreased. Therefore two regression lines were fitted. This was 
accomplished by comparing the explained variance of the two regression lines 
with that of a straight line. The two lines significantly increased the explained 
variance. The explained variance of the model based on two regression lines was 
also slightly higher than the explained variance of a model including a quadratic 
term. The 'breakpoint' in the line was determined by optimizing the explained 
variance. The analysis was performed with two time variables: one for the total 
period (Bj) and one for the period after the breakpoint (Bj). The change in 
systolic blood pressure and percentage hypertensives over the first period (until 
the breakpoint) is given by B l 5 the change over the second period (after the 
breakpoint) is given by Bj + B 2 . The interpretations of the results from both the 
CB Heart Project and the RIFOH Project are based on the age and town 
adjusted regression coefficients. 
RESULTS 
CB Heart Project (1974-1980) 
Table 1 shows the regional differences in blood pressure and body mass index 
in both men and women. For men mean systolic blood pressure in Doetinchem 
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and Tilburg was significantly higher when compared with the other towns. 
Diastolic blood pressure in Amsterdam was significantly higher than in Tilburg 
and Maastricht. For women systolic blood pressure in Doetinchem was 
significantly higher than in the other towns and diastolic blood pressure in 
Doetinchem was significantly higher than in Maastricht and Tilburg. For both 
men and women the mean body mass index was significantly higher in 
Doetinchem when compared with the other towns. 
Table 1. Mean blood pressure (mmHg) and body mass index (kg/m2) adjusted for age in men 
and women aged 37-43 years in the period 1974-1980, by town (CB Heart Project) (between 
brackets standard deviation) 
Systolic blood Diastolic blood Body mass Number 
pressure pressure index 
Men 
Amsterdam 132.1 (15.9) 82.0 (11.0) 24.8 (3.1) 3,481 
Doetinchem 134.7 (16.2) 80.0 (10.7) 25.4 (2.8) 1,818 
Maastricht 132.8 (17.0) 81.6 (11.9) 25.0 (3.1) 3,678 
Tilburg 134.2 (15.2) 80.5 (10.2) 24.9 (3.1) 5,165 
Women 
Amsterdam 125.4 (16.9) 77.8 (11.1) 24.1 (3.7) 4,185 
Doetinchem 130.6 (17.1) 78.5 (10.8) 25.4 (3.6) 1,999 
Maastricht 124.8 (16.1) 77.3 (10.9) 24.1 (3.5) 3,810 
Tilburg 129.0 (15.9) 77.4 (10.1) 24.3 (3.7) 5,387 
Tables 2 and 3 show the mean systolic and diastolic blood pressure, the 
prevalence of hypertension and the percentage treated hypertensives for men and 
women in the period 1974-1980. For men, a significant overall increase in mean 
systolic blood pressure was observed after adjustment for age and town between 
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1974 and 1980 (Table 4). This was due to a significant increase of 1.56 mmHg 
per year in Doetinchem. A significant increase in mean diastolic blood pressure 
was observed after adjustment for age and town. This increase was significant 
in all towns except Tilburg. Both the percentage hypertensive men and the 
percentage treated hypertensive men increased significantly. 
For women, no significant changes in mean systolic blood pressure was 
observed; this was consistent in all towns. The mean diastolic blood pressure 
increased significantly after adjustment for age and town. This increase was due 
to an increase in the mean diastolic blood pressure of 0.55 mmHg per year in 
Amsterdam and 0.97 mmHg per year in Maastricht. Both the percentage 
hypertensive women and the percentage treated hypertensive women did not 
change. The percentage of hypertensives was lower among women compared 
with men. Hypertensive women were, however, more frequently treated than 
hypertensive men. 
Table 2. Mean blood pressure, prevalence of hypertension and percentage treated 
hypertensives, men aged 37-43 years in the period 1974-1980 (CB Heart Project)1 
19742 19752 1976 1977 1978 1979 19803 
N 452 1,070 3,370 2,972 2,805 1,738 1,735 
Systolic blood pressure 
Mean (mmHg) 130.8 130.9 133.9 133.9 133.0 134.1 131.9 
(SD) 13.6 13.1 16.7 16.8 16.3 16.2 14.9 
Diastolic blood pressure 
Mean (mmHg) 79.6 78.3 80.6 81.1 81.3 82.9 82.1 
(SD) 10.3 10.0 10.9 11.4 11.1 11.3 10.1 
Hypertension (%)4 8.6 7.8 13.5 15.9 15.9 17.4 12.7 
Treated for hypertensives (%) 12.8 20.9 13.2 14.3 16.6 16.3 23.1 
1 data adjusted for age 
2 data from Amsterdam and Doetinchem were not available 
3 data from Doetinchem were not available 
4 systolic blood pressure SI60 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
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Table 3. Mean blood pressure, prevalence of hypertension and percentage treated 
hypertensives, women aged 37-43 years in the period 1974-1980 (CB Heart Project)1 
19742 19752 1976 1977 1978 1979 19803 
N 511 1,175 3,462 3,368 2,991 1,949 1,925 
Systolic blood pressure 
Mean (mmHg) 127.8 127.6 128.5 126.8 126.4 127.3 126.2 
(SD) 15.2 16.0 16.9 17.1 16.8 16.6 14.5 
Diastolic blood pressure 
Mean (mmHg) 78.3 76.6 77.3 77.3 77.6 78.4 78.6 
(SD) 10.3 10.5 10.8 10.8 10.5 10.9 10.3 
Hypertension (%)4 7.8 8.4 10.4 10.7 11.2 11.0 10.1 
Treated for hypertension (%) 56.1 45.7 33.9 31.5 40.3 31.0 34.9 
1 data adjusted for age 
2 data from Amsterdam and Doetinchem were not available 
3 data from Doetinchem were not available 
4 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
RIFOH Project (1981-1986) 
Table 5 shows that systolic blood pressure in Doetinchem and Tilburg was 
higher when compared to the other towns. Diastolic blood pressure in 
Doetinchem was significantly higher than in Leiden, Maastricht and Tilburg. 
Body mass index in Doetinchem and Maastricht was significantly higher when 
compared with the other towns. 
Table 6 shows the mean systolic and diastolic blood pressure, the 
prevalence of hypertension and the percentage treated hypertensives for men in 
the period 1981-1986. After adjustment for age and town a significant increase 
in mean systolic blood pressure was observed from July 1981 until December 
1983 (Table 7). This increase was due to an increase in all towns except 
Tilburg. Between January 1984 and September 1986 a significant decrease was 
observed, due to decreases in Amsterdam, Leiden and Maastricht. The 'net' 
change in mean systolic blood pressure over the total study period was 
insignificant (< 1 mmHg). The mean diastolic blood pressure decreased 
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significantly after adjustment of age and town between 1981 and 1986. This was 
due to a decrease in mean diastolic blood pressure in Amsterdam, Leiden and 
Maastricht while in Doetinchem and Tilburg no changes were observed. The 
percentage hypertensive men did not change significantly between July 1981 and 
December 1983. From January 1984 until September 1986 the percentage 
hypertensives decreased significantly. The 'net' change in the prevalence of 
hypertensives between 1981 and 1986 was insignificant. The percentage treated 
hypertensives increased significantly between 1981 and 1986. 
Table 4. Regression coefficients (B) and intercepts for the relation between blood pressure 
or percentage hypertensives or percentage treated hypertensives and time for men and women 
aged 37-43 years in the period 1974-1980 (CB Heart project). 
Men (n=14,142) 
Crude Adjusted1 
Women (n=15,381) 
Crude Adjusted1 
Mean systolic blood pressure 
intercept 
B (mmHg/year) 
Mean diastolic blood pressure 
intercept 
B (mmHg/year) 
Hypertension % 2 
intercept 
B (%/year) 
Treated hypertensives % 
intercept 
B (%/year) 
133.1 
0.06 
78.9 
0.67*** 
11.4 
0.95*** 
12.9 
1.49* 
130.9 
0.33* 
79.9 
0.58*** 
12.7 
0.81** 
8.3 
2.04** 
129.2 
-0.55** 
77.2 
0.19 
10.5 
0.08 
42.1 
-1.48 
125.6 
-0.07 
76.7 
029*** 
8.5 
0.39 
28.0 
0.05 
1 data adjusted for age and town 
2 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
* p<0.05; ** p<0.01; *** p<0.001 
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Table 5. Mean blood pressure (mmHg) and body mass index (kg/m2) adjusted for age in men 
aged 33-37 years in the period 1981-1980, by town (RIFOH Project) (between brackets 
standard deviation) 
Systolic 
blood pressure 
Diastolic 
blood pressure 
body mass 
index 
Number 
Amsterdam 128.7 (15.0) 79.4 (10.1) 24.4 (3.2) 21,645 
Doetinchem 132.8 (15.0) 79.5 (10.6) 25.0 (3.0) 13,425 
Leiden 125.9 (14.4) 78.7 (10.0) 24.4 (2.9) 14,158 
Maastricht 130.5 (15.5) 79.0 (10.4) 25.0 (3.1) 16,349 
Tilburg 132.3 (15.1) 77.8 (9.3) 24.7 (3.1) 15,147 
Table 6. Mean blood pressure, prevalence of hypertension and percentage under treatment for 
men aged 33-37 years in the period 1981-1986 (RIFOH Project)1 
1981 1982 1983 1984 1985 1986 
N 8,083 12,252 17,633 14,870 15,882 12,004 
Systolic blood pressure 
Mean (mmHg) 127.9 129.6 130.8 131.1 129.9 129.1 
(SD) 14.7 15.5 15.5 14.8 15.2 15.2 
Diastolic blood pressure 
Mean (mmHg) 80.4 80.5 79.6 79.0 77.1 77.5 
(SD) 9.9 10.5 10.2 8.9 7.6 7.8 
Hypertension (%)2 9.2 10.5 10.2 8.99 7.6 7.8 
Treated for hypertension (%) 13.0 8.8 11.2 10.3 13.3 13.0 
1 data adjusted for age 
2 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
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Table 7. Regression coefficients (B) and intercepts for the relation between blood pressure 
or percentage hypertensives or percentage treated hypertensives and time, and the 'net' 
change1 over the total study period for men (n=80,724) aged 37-43 years in the period 1981-
1986 (RIFOH Project). 
Crude Adjusted2 
Mean systolic blood pressure 
intercept 
B (mmHg from July 1981-December 1983) 
B (mmHg from January 1984-September 
1986) 
'Net' July 1981-September 1986 
Mean diastolic blood pressure 
intercept 
B (mmHg/year) 
Hypertensives (%)3 
intercept 
B (% from July 1981-December 1983) 
B (% from January 1984-September 1986) 
'Net' July 1981-September 1986) 
% Treated hypertensives 
intercept 
B (%/year) 
127.8 
1.51*** 
-1 13*** 
0.66 
81.0 
-0.75*** 
10.0 
-0.10 
-1.01*** 
-0.53 
10.0 
0.73* 
126.4 
1.58*** 
-1.21*** 
0.64 
81.3 
-0.73*** 
9.6 
-0.06 
-1 
-0.42 
9.1 
0.74* 
1 calculated as the predicted value in the first month minus the predicted value in the last 
month, based on the regression equation 
2 data adjusted for age and town 
3 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication. 
* p<0.05; *** p<0.001 
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DISCUSSION 
The prevalence of hypertension increased from 12.7% in 1974 to 17.8% in 1980 
for 40-year-old men but remained stable at 9.6% in 35-year-old men between 
1981 and 1986. For 40-year-old women the prevalence of hypertension was 
8.5% in 1974 and did not change between 1974-1980. Due to lack of 
information it was not possible to divide hypertension into primary and 
secondary hypertension. The advantage of the present study was that blood 
pressure was measured in a standardized way in both periods. A disadvantage 
of the present study was that only one cuff size was used, which can bias the 
blood pressure measurement (7). However, from the Monitoring Risk Factor 
Project, an ongoing screening project carried out in The Netherlands, it was 
shown that in only 1.5% of the subjects another cuff size was used (8) because 
young adults in the Netherlands are relatively lean (9). 
In the periods 1974-1980 and 1981-1986, response rates between 70-80% 
were observed in 4 of the 5 Dutch towns participating in the present study. In 
Amsterdam the response rate amounted to 55% in the period 1981-1986. In the 
nationwide Health Surveys carried out by the Central Bureau of Statistics in the 
Netherlands the lowest response rate was also observed in Amsterdam (10). In 
the present study we are primarily interested in the trend in blood pressure. It 
is unlikely that this trend is influenced by the relatively low response rate in 
Amsterdam because the response rate in Amsterdam was fairly constant between 
1981 and 1986. 
In the present study the prevalence of hypertension might be 
overestimated since the blood pressure of each subject was only measured once. 
To obtain an indication of the order of magnitude of the overestimation on the 
prevalence of hypertension due to a single blood pressure measurement, data 
from the Monitoring Risk Factor Project, an ongoing screening project carried 
out in the Netherlands, were used (8). In this study blood pressure is measured 
twice with a random zero sphygmomanometer by trained technicians. These data 
were used to estimate the influence of the use of one measurement instead of 
the average of two measurements on the prevalence of hypertension among men 
and women of the same age range. The results of these analyses suggest that the 
prevalence of hypertension may be overestimated by 9% for men aged 37-43 
years, 10% for women aged 37-43 years and 7% for men aged 33-37 years. This 
means that the average prevalence of hypertension would have been 11.6% 
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instead of 12.7% for men and 7.7% instead of 8.5% for women in the CB-
project and for men in the RIFOH project it would have been 8.9% instead of 
9.6%. 
Other studies on trends in blood pressure in subjects of the same age 
range are not available. However, trends in blood pressure can be compared 
between studies because the trends within studies are of primary interest and not 
the level of blood pressure itself, which is highly dependent on age. In Italy the 
mean systolic and diastolic blood pressure of men and women aged 20-59 years 
in 1978/1979 were compared with those of individuals examined in 1983/1984 
(11). Systolic blood pressure was lower (1.3 mmHg for men and 4.0 mmHg for 
women) in 1983/1984 compared to 1978/1979. Diastolic blood pressure 
decreased by 1.8 mmHg in men and 3.3 mmHg in women in this period. In the 
Minnesota Heart Survey systolic and diastolic blood pressure values for men and 
women aged 25-59 years in 1973/1974 were compared with the values in 
1985/1987 (12). Age-adjusted systolic blood pressure levels declined by 1.2 
mmHg for men and 2 mmHg for women between 1973 and 1987. Mean age-
adjusted diastolic blood pressure levels decreased significantly in both men and 
women by 2.6 and 1.5 mmHg, respectively. In Japan trends in blood pressure 
were studied in men and women aged 40-49 years in the period 1956-1980 (13). 
No changes in blood pressure were observed for Japanese men between 1964-
1980 while blood pressure decreased in Japanese women in the same period. 
Both men and women in Italy and The United States and women in Japan 
exhibited a decrease in systolic and diastolic blood pressure whereas the present 
study did not show a decrease during the period 1974-1986. 
The prevalence of hypertension is highly dependent on the definition used 
and the age distribution of the population studied. Results from comparable 
studies were not available. However, the trend in the prevalence of hypertension 
can be compared between studies using different definitions of hypertension and 
different age ranges. In the Minnesota Heart Survey the prevalence of 
hypertension (diastolic blood pressure >90 mmHg and/or use of antihypertensive 
medication) in 1973/74 was compared with values in 1980/82 (14). For both 
men and women aged 25-59 years no change in the prevalence of hypertension 
was observed. Also in the present study no change in the prevalence in 40-year-
old women was observed in the same period. However, the prevalence of 
hypertension increased in 40-year-old Dutch men during that period. 
Between 1974 and 1980 the percentage treated hypertensives in The 
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Netherlands increased from 8% to 21% of the 40-year-old men and from 9% to 
13% of the 35-year-old men between 1981 and 1986. The percentage treated 
hypertensive 40-year-old women was around 28% in 1974 and remained stable 
between 1974-1980. In Italy the proportion treated hypertensive men increased 
from 15.5% in 1978/1979 to 27.7% in 1983/1984 (11). Between 1978/1979 and 
1983/1984 the proportion treated hypertensive women increased from 26.9% to 
40.2%. In the Minnesota Heart Survey the age-adjusted use of antihypertensive 
medication increased from 1973/74 (4.5% of the men, 5.1% of the women) to 
1980/82 (8.6% of the men, 7.9% of the women) (14). The prevalence of 
hypertension in 1973/74 was 17% for men and 11.8% for women. In 1980/82 
the prevalence for men was 17.7% and for women 12.9%. As in both cases the 
use of antihypertensive medication as a fraction of the total population was 
similar for men and women, the fraction of treated hypertensive women was 
higher than that of men. The results from these studies show that in The 
Netherlands, Italy and the United States more women were treated for 
hypertension than men. 
An increase in average systolic blood pressure in men between 1974-1980 
was followed by an insignificant change between 1981-1986. Average diastolic 
blood pressure increased between 1974-1980 but decreased with the same 
amount between 1981-1986. Between 1974-1980 average systolic blood pressure 
did not change in women while average diastolic blood pressure decreased 
during that period. An increase in the prevalence of hypertension in young adult 
men was observed in the period 1974-1980. This increase can be partly due to 
better reporting or more public awareness because in the CB Heart Project, 
between 1974-1980 the use of antihypertensive medication increased by 2.3%. 
On the other hand the increase in average body mass index of 0.5 kg/m2 
between 1974-1980 could also have played a role in the average increase in 
hypertension (9). 
The observed trends in blood pressure in The Netherlands are in contrast 
with the trends in Italy, the United States and Japan. In those countries a 
decrease in blood pressure was observed with the exception of Japanese men, 
who did not show a change in blood pressure level. Possible reasons for this 
discrepancy are that important determinants of blood pressure such as sodium 
intake, alcohol intake and body mass index did not decrease between 1974-1986 
in The Netherlands (9,15). We also did not have a National High Blood Pressure 
Education Program as in the United States (16). This program resulted in a 
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LEVELS AND TRENDS IN BLOOD PRESSURE AND 
PREVALENCE, AND TREATMENT OF HYPERTENSION IN 
THE NETHERLANDS, 1987-1991 
ABSTRACT 
Levels and trends in blood pressure, as well as prevalence and treatment of hypertension, 
were studied in the Netherlands between 1987 and 1991. Blood pressure was measured 
continuously using a standardized method in 36,273 men and women 20-59 years of age. The 
data were weighted for the age distribution of the general Dutch population in 1990 and 
adjusted for each technician who measured the blood pressure. In summer in both men and 
women, systolic blood pressure was about 1.5-2.0 mmHg lower than in the other seasons, and 
diastolic blood pressure was 0.5-1.0 mmHg lower. In 1987 systolic blood pressure was 124 
mmHg in men and 117 mmHg in women. Diastolic blood pressure was 78 mmHg in men and 
75 mmHg in women. The prevalence of hypertension was 8% in both men and women. 
Between 1987 and 1991, systolic blood pressure decreased slightly while diastolic blood 
pressure increased slightly. The prevalence of hypertension did not change in this period. The 
percentage of treated hypertensive men decreased significantly from 44% in 1987 to 34% in 
1991 and from 60% to 49% in women. We conclude that the prevalence of hypertension did 
not change between 1987 and 1991, yet the treatment of hypertension decreased, possibly due 
to a change in the pattern of treatment by Dutch physicians. 
Edith M. van Leer, Jacob C. Seidell, Daan Kromhout. 
American Journal of Preventive Medicine 1994;10:194-199. 
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INTRODUCTION 
Increased blood pressure is one of the major risk factors for cardiovascular 
diseases (1-3). From a public health point of view it is important to get insight 
in the levels and trends in blood pressure, as well as on the prevalence and the 
treatment of hypertension. We have previously described trends in blood 
pressure and in the prevalence and treatment of hypertension, during the period 
1974 to 1980 for both sexes 37-43 years of age and during the period 1981 to 
1986 for men 33-37 years of age (4). In 1987 we started the Monitoring Project 
on Cardiovascular Risk Factors, in which random samples of individuals aged 
20-59 years of age are investigated yearly (5). The aim of this project was to 
study the levels and trends in major risk factors for cardiovascular diseases. For 
this study we used data collected between 1987 and 1991 to study levels and 
trends in blood pressure, prevalence, and treatment of hypertension in both men 
and women. In addition, we investigated seasonal variation in blood pressure. 
METHODS 
The Monitoring Project on Cardiovascular Risk Factors is an ongoing screening 
project that started in 1987. The project is carried out in basic health services 
in Amsterdam, Doetinchem, and Maastricht, located in different parts of the 
Netherlands: Amsterdam, the capital city in the west; Doetinchem, a small town 
in the east; and Maastricht a town in the south. Each year we selected a new 
random sample of men and women 20-59 years of age in each city. The random 
sample was selected from the civil registry in each town. To obtain equal 
numbers in each age category, we stratified the sample according to gender and 
five-year age classes. In Doetinchem and Maastricht, 400 persons were selected 
per stratum; in Amsterdam, 500 because of the lower response there. The overall 
response rate was about 50% for men and 57% for women. From 1987 until 
1991 we examined about 36,000 men and women. 
In this study, we measured blood pressure, height, and weight were 
measured and draw blood for total and high density lipoprotein cholesterol 
determination. Using a random zero sphygmomanometer, we measured blood 
pressure with the subject in a sitting position. Trained technicians who were all 
instructed by the same physician conducted the measurements. The cuff (size 12 
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x 23 cm) was applied to the left upper arm. A larger (15 x 33 cm) or a smaller 
(9 x 18 cm) cuff was used when appropriate. In about 1.1% of the subjects, a 
larger cuff was used, and in about 0.4% of the subjects a smaller cuff was used. 
Systolic blood pressure, was recorded at the appearance of sounds (first-phase 
Korotkoff), and the diastolic blood pressure was recorded at the disappearance 
of sounds (fifth-phase Korotkoff). After the first measurement, the heart rate was 
measured for 30 seconds followed by a second blood pressure measurement. For 
the analyses, we used the average of the two blood pressure measurements. We 
asked the subjects to fill out a questionnaire from which information was 
obtained about demographic variables, presence and family history of 
cardiovascular diseases, presence of a number of other chronic diseases, current 
medication use, a prescribed diet status, use of alcohol, smoking habits, physical 
activity, psychosocial factors, selected dietary habits, and, for women, 
reproductive history. We exclude pregnant women (n = 306) from the analyses. 
We divided age groups in the following 10-year age categories: 20-29, 30-
39, 40-49 and 50-59 years. The seasons were defined to coincide with quarters: 
winter (January, February, March), spring (April, May, June), summer (July, 
August, September) and fall (October, November, December). Education was 
divided into three levels: low, intermediate and high. Hypertension was defined 
according to the criteria of a World Health Organization (WHO) expert 
committee as a systolic blood pressure >160 mmHg and/or a diastolic blood 
pressure >95 mmHg and/or use of antihypertensive medication (2). 
A nonresponse study has been performed among 1,620 subjects who had 
been invited for the first time between august and December 1991 (5). In 
April/May 1992 they were approached for a second time by telephone (75%) or 
by mail for those who did not have a telephone (25%). The response was 61%, 
23% could not be reached and 16% refused to participate. Information was 
obtained on demographic variables including educational level, use of alcohol, 
smoking habits, weight, and height. 
Statistical analyses 
Analysis of variance was used to estimate mean blood pressure, prevalence of 
hypertension and percentage of treated hypertensives per year or per season. The 
percentage of treated hypertensives represents of those with hypertension who 
received treatment. Blood pressure was analyzed as a continuous variable and 
the presence and treatment of hypertension, as dichotomous variables. The data 
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RESULTS 
Table 1 presents mean blood pressure, the prevalence of hypertension, and the 
percentage of those with hypertension who received treatment for both men and 
women per 10-year age category. Both for men and women, systolic and 
diastolic blood pressure increased with age. In all 10-year age categories, mean 
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were weighted to the age distribution of the general Dutch population in 1990 
because in the study population the age distribution was shifted toward older 
age. About 9% of the studied subjects were 20-29 years compared to about 15% 
in the Dutch population in 1990 while about 14% of the studied subjects were 
50-59 years compared to 9% in the Dutch population. The data, were also 
adjusted for the technicians who measured the blood pressure. We adjusted for 
technician because analyses showed some differences in average blood pressure 
measured by different technicians. 
We used regression analysis to examine the relation between blood 
pressure, prevalence and treatment of hypertension and time (months). We 
adjusted for technician by adding dummy variables for different technicians to 
the model. One of the technicians served as the reference. We also used 
regression analysis to test whether average blood pressure in winter, summer, 
and fall differed from blood pressure in spring. Three dummy variables for 
season were entered in the model. 
To test whether the trends in mean blood pressure differed among the 
three towns, the various 10-years age categories, and the various educational 
levels, we entered cross-product terms (town*month), (age group*month) or 
(educational level*month) in the regression model. In general, we present 
regression coefficients of the pooled towns in our tables. We specified trends in 
mean blood pressure that differed significantly among the three towns, or the 
different age groups or the different levels of education. We also studied trends 
by quartiles of blood pressure to indicate whether these changes are differential 
across blood pressure levels. The cutoff points were based on quartiles of 
systolic and diastolic blood pressure for both men and women. The 
interpretations of the results are based on the regression coefficients, weighted 
to the age distribution of the general Dutch population in 1990 and adjusted for 
technicians. 
Chapter 3 
systolic and diastolic blood pressure were higher in men than in women. The 
prevalence of hypertension also increased with age. The prevalence of 
hypertension was higher for men than for women except in the oldest age 
category, where the prevalence in both sexes was about 19%. In all age 
categories, a higher percentage of women was treated for hypertension than men. 
Table 1. Mean blood pressure, prevalence of hypertension1 and percentage of treated 
hypertensive2 men and women per 10-year age category in the period 1987-1991 
20-29 30-39 40-49 50-59 
Men 
Number 3103 4483 4908 4646 
Systolic blood pressure (mmHg) 121.4 121.3 123.7 129.1 
Standard deviation 11.6 12.3 14.0 16.9 
Diastolic blood pressure (mmHg) 73.4 76.3 79.8 81.3 
Standard deviation 8.7 9.5 10.0 10.2 
Prevalence of hypertension (%) 1.8 4.4 10.5 18.9 
Treated hypertension (%) 10.9 21.3 35.8 52.0 
Women 
Number 3615 4986 5254 5278 
Systolic blood pressure (mmHg) 111.2 111.3 116.8 125.1 
Standard deviation 10.6 11.7 15.1 17.3 
Diastolic blood pressure (mmHg) 70.1 71.6 75.3 78.8 
Standard deviation 8.5 9.0 9.9 10.3 
Prevalence of hypertension (%) 1.0 2.1 7.3 18.8 
Percentage treated for hypertension (%) 27.8 49.5 52.6 66.1 
1 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
2 the percentage of those with hypertension who received treatment 
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Table 2 indicates mean blood pressure, the prevalence of hypertension, and the 
percentage of those with hypertension who received treatment per year for both 
men and women. Table 3 shows the intercepts, which give an estimation of 
mean blood pressure, the prevalence of hypertension, and the percentage of 
treated hypertensive patients in 1987 measured by the technician who served as 
reference category. The intercepts are not the same as the mean values in 1987, 
which appear in Table 2. In Table 3 also shows the regression coefficients 
indicating the average change per month in blood pressure, prevalence, and 
treatment of hypertension. Systolic blood pressure showed a small but significant 
decrease between 1987 and 1991, whereas diastolic blood pressure showed a 
small but significant increase. Figures 1 and 2 show that the changes in systolic 
and diastolic blood pressure in both men and women were minor between 1987 
and 1991. When subjects with hypertension were excluded from the analyses, 
the decrease in systolic blood pressure in both men and women was slightly 
stronger, whereas the increase in diastolic blood pressure was slightly weaker. 
The results for the trends remained the same. 
The prevalence of hypertension did not change in the period from 1987 
to 1991. The percentage of treated hypertensives, however, decreased 
significantly by 12% in men and 18% in women. When hypertension was 
defined as a systolic blood pressure >140 mmHg and/or diastolic blood pressure 
>90 mmHg and/or use of antihypertensive medication, the trend for the 
prevalence of hypertension was similar to the trend for the prevalence of 
hypertension defined according to the WHO criteria. When hypertension was 
defined as a systolic blood pressure >140 mmHg and/or diastolic blood pressure 
>90 mmHg and/or use of antihypertensive medication the percentage of treated 
hypertensive men did not change, but the percentage of treated hypertensive 
women decreased. When dietary treatment for hypertension was included in the 
definition of hypertension (systolic blood pressure >160 and/or diastolic blood 
pressure >95 and/or use of antihypertensive medication and/or dietary treatment), 
the percentage of hypertensive men treated with diet did not change, but 
treatment with medication or with both medication and diet decreased by 11% 
and 9%, respectively. In women, the percentage of dietary treatment, treatment 
with medication or with both medication, and a diet decreased by 14%, 10%, 
15%, respectively. 
Crude trends in mean blood pressure differed significantly among the 
towns, but after adjustment for technician the differences were negligible. 
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Table 2. Mean blood pressure, prevalence and percentage treated hypertensive1 , 2 in men and 
women aged 20-59 years in the period 1987-19913 
1987 1988 1989 1990 1991 
Men 
Number of subjects 3,006 3,853 3,495 3,258 3,525 
Mean SBP (mmHg) 124.2 124.0 123.1 122.0 123.0 
Mean diastolic blood pressure (mmHg) 78.2 77.8 78.7 78.3 79.0 
Prevalence of hypertension (%) 8.1 7.7 8.8 7.6 9.2 
Percentage treated for hypertension (%) 43.8 40.0 31.8 29.4 33.5 
Women 
Number of subjects 3,283 4,302 3,975 3,627 3,942 
Mean Systolic blood pressure (mmHg) 116.6 116.5 115.8 114.5 116.1 
Mean Diastolic blood pressure (mmHg) 74.7 74.0 74.9 74.3 75.2 
Prevalence of hypertension (%) 7.6 7.1 7.1 5.3 7.6 
Percentage treated for hypertension (%) 60.0 63.5 51.5 49.5 48.7 
1 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
2 the percentage of those with hypertension who received treatment. 
3 weighted for the age distribution of the general Dutch population in 1990 and adjusted for 
technician 
Therefore, we show only overall regression coefficients. The trends in mean 
systolic blood pressure level did not differ between the 10-year age categories, 
and, for women also, the trend in mean diastolic blood pressure did not differ 
between the 10-year age categories. Diastolic blood pressure increased 0.034 
mmHg/month in men 20-29 years, whereas in men 30-59 years, blood pressure 
did not change. In men systolic and diastolic blood pressure decreased in the 
lowest quartile, but, in the other quartiles did not change. In women, systolic 
and diastolic blood pressure did not change in any quartile. In both men and 
women, trends in mean systolic and diastolic blood pressure did not differ 
among groups with different levels of education. 
32 
Trends in blood pressure, 1987-1991 
Table 3. Intercepts and regression coefficients (B) for the relation between blood pressure, 
prevalence and percentage treated for hypertensives1 , 2 and time (months) for men and women 
20-59 years of age, 1987-19913 
MEN WOMEN 
Systolic blood pressure 
intercept (mmHg) 123.6 115.1 
B (mmHg/month) -0.040 -0.026 
95 % confidence interval (-0.054, -0.027) (-0.039, -0.013) 
Diastolic blood pressure 
intercept (mmHg) 77.8 73.7 
B (mmHg/month) 0.018 0.011 
95 % confidence interval (0.009,0.027) (0.003,0.020) 
Prevalence of hypertension 
intercept (%) 7.9 5.8 
B (%/month) 0.017 -0.010 
95 % confidence interval (-0.009,0.044) (-0.032,0.013) 
Percentage treated for hypertension 
intercept (%) 53.8 69.8 
B (%/month) -0.203 -0.298 
95 % confidence interval (-0.348, -0.059) (-0.450, -0.146) 
1 systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or use 
of antihypertensive medication 
2 the percentage of those with hypertension who received treatment 
3 data are weighted for the age distribution of the general Dutch population in 1990 and 
adjusted for technician 
Table 4 shows mean systolic and diastolic blood pressure per season for both 
men and women. Systolic and diastolic blood pressure were significantly lower 
in summer than in spring for both men and women. In men, systolic blood 
pressure was significantly higher in winter than in spring, and in women, 
systolic blood pressure was significantly higher in fall than in spring. Diastolic 
blood pressure was significantly higher in fall than in spring in men. In women, 
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diastolic blood pressure was significantly higher in fall and winter than in 
spring. 
Table 4. Mean systolic and diastolic blood pressure1 per season in men and women in the 
period 1987-1991 
Men Women 
Systolic blood pressure 
Spring 
Summer 
Fall 
Winter 
F-value2 
123.6 
122.1*** 
123.7 
124.3* 
34.8*** 
116.1 
114.6*** 
116.8* 
116.7 
22.4*** 
Diastolic blood pressure 
Spring 
Summer 
Fall 
Winter 
F-value2 
78.4 
77 8*** 
78.8* 
78.7 
65.4*** 
74.6 
73.9*** 
75.1** 
75.0* 
66.5*** 
1 weighted to the age distribution of the Dutch population in 1990 and adjusted for technician 
2 F-value was obtained from variance analysis. 
* p <0.05 (significantly different from spring = reference category). 
** p <0.01 (significantly different from blood pressure in spring). 
*** p <0.001 (significantly different from blood pressure in spring). 
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Figure 1. Mean systolic blood pressure weighted for the age distribution of the general Dutch 
population in 1990 and adjusted for technician per quarter for men and women 20-59 years 
of age, 1987-1991. 
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Figure 2. Mean diastolic blood pressure weighted for the age distribution of the general 
Dutch population in 1990 and adjusted for technician per quarter for men and women 20-59 
years of age, 1987-1991. 
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DISCUSSION 
The advantage of this study was that blood pressure was measured continuously 
in a standardized method in a large number of men and women with a wide age 
range. Continuous measurements over a long period are desirable to establish 
reliable trends. The trends of this study were based on a five-year period. Trends 
in blood pressure and hypertension and their cardiovascular sequelae are of great 
public health importance because of the insights provided about their 
determinants and continuing contribution to national morbidity and mortality (6). 
In the future, it may be possible to present trends over a longer period because 
continuation of the measurements is being planned. 
This study, the overall response rate was 54%, which could have been 
a source of bias. Obviously, in the nonresponders, blood pressure could not be 
measured (5). Instead, we used educational level, alcohol consumption, and 
smoking to estimate potential bias. Education, a known determinant of 
nonresponse, is associated with blood pressure and hypertension. From the non-
response study, it appeared that the calculated distribution of educational level 
among responders and nonresponders was similar. In both men and women, the 
percentage of alcohol users was higher among the responders than among the 
nonresponders. In men, the percentage of smokers was higher among the non-
responders than among the responders. In women, the percentage of smokers 
was similar among responders and nonresponders. It appeared that the average 
blood pressure level was similar to the blood pressure level weighted for the 
distribution drinkers and nondrinkers in the nonresponse survey. In men, average 
systolic and diastolic blood pressure was about 1 mmHg lower than the blood 
pressure level weighted for the distribution smokers and nonsmokers. These 
results suggest that the low response rate probably did not affected blood 
pressure levels. 
This study the, response rate decreased from 57% in 1987 to 51% in 
1991. Possible changes in educational level, alcohol and coffee consumption, 
body mass index (BMI) and smoking among the nonresponders also could have 
biased the results of the trend analysis. Therefore, we adjusted the data for 
educational level, alcohol and coffee consumption, BMI, and smoking. The 
changes in the regression coefficients for systolic and diastolic blood pressure, 
the prevalence, and the treatment for hypertension were negligible after 
adjustment for these potential confounders. 
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The percentage of subjects in this study who required a larger cuff was 
low because adults in The Netherlands are rather lean. The average BMI in this 
study was about 25 kg/m2. The percentage of subjects who required a larger cuff 
decreased steadily from 2.1% in 1987 to 0.7% in 1991. The decrease in the use 
of a larger cuff could bias the results of the trend analysis. The use of too small 
a cuff size results in an overestimation of the blood pressure (7). By using too 
smaller a cuff technicians can overestimate blood pressure by about 6 mmHg in 
men and by about 4 mmHg in women. Therefore, the blood pressure levels of 
obese subjects (BMI greater than 30 kg/m2) were corrected for the use of an 
inappropriate cuff size by subtracting 6 mmHg for men and 4 mmHg for women 
in an additional analysis. The changes in the regression coefficient for systolic 
and diastolic blood pressure, prevalence, and treatment of hypertension were, 
however, negligible after correcting blood pressure for this measurement error. 
We observed seasonal variation in blood pressure in this study in both 
men and women. Seasonal variation in blood pressure has been studied in some 
other studies. One study observed that diastolic blood pressure in 22 subjects in 
the high-to-mild hypertension range was significantly higher in the cold season 
than in the warm season (8). Systolic blood pressure was also higher in the cold 
season but did not reach statistical significance. Giaconi et al. observed in their 
study that, in adults, both systolic and diastolic blood pressure were significantly 
higher in the cold than in the warm season (9). In Finland in 801 men 50 years 
of age and older, systolic and diastolic blood pressure revealed significant 
seasonal patterns with peaks in spring and late autumn and troughs in mid-
winter and summer (10). The results of these studies and of this study support 
the importance of considering seasonal variation in epidemiological studies, 
particularly when changes in blood pressure over time are evaluated. 
Mean levels of blood pressure, prevalence, and treatment of hypertension 
cannot be compared between different studies or different study periods because 
of the differences in blood pressure measurements, age ranges, and the 
definitions used for hypertension. However, trends in the prevalence and 
treatment of hypertension from different studies can be compared. The 
Netherlands trends in prevalence and treatment of hypertension in men and 
women 37-43 years of age have been studied over the period 1974-1980, and 
in men 33-37 years of age, over the period 1981-1986 (4). The prevalence of 
hypertension hardly changed in adults from 1974 to 1986, with the exception of 
a slight increase in men from 1974 to 1980. From 1974 to 1986, the percentage 
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of treated hypertensive men increased but from 1987 to 1991 the percentage of 
treated hypertensive men decreased. The percentage of treated hypertensive 
women did not change over the period 1974-1980, yet over the period 1987-
1991 the percentage of hypertensive women decreased. 
Other countries' trends in the prevalence and treatment of hypertension 
until 1987 are available in the literature (11-15). In Israel and in the Minnesota 
Heart Study the prevalence of hypertension did not change during the previous 
10 to 15 years, although in Japan the prevalence of hypertension decreased 
between 1964 and 1980. The treatment of hypertension increased in Israel, Japan 
and Italy during the seventies and early eighties, but in the Minnesota Heart 
Study the treatment of hypertension did not change during that period. In The 
Netherlands, a decrease in treatment of hypertension has been observed, but 
such a decrease has not been observed in other countries. In the United States, 
the National High Blood Pressure Education Program was started already in 
1972 (16). From that time onward, physicians were trained to diagnose and treat 
hypertension according to specific guidelines. Such efforts to increase the 
awareness of the importance of the diagnosis and treatment of hypertension were 
not undertaken in The Netherlands. 
The decrease in treatment of hypertension was stronger in this study in 
women than in men. However, the percentage of treated hypertensive women 
was still higher than the percentage of treated hypertensive men. Perhaps 
because women consult a physician more often than men (17). The decrease in 
treatment of hypertension in both men and women could result from the debate 
in the mid-eighties among general practitioners in The Netherlands about the 
usefulness of drug treatment for mild hypertensives (18). Afterward physicians 
started to base the hypertension diagnosis on more blood pressure measurements 
instead of a single measurement (19). This resulted in a reduction of the number 
of patients treated for hypertension because only "real" hypertensives were 
treated. However, even with hypertension defined as systolic blood pressure 
>140 or diastolic blood pressure >90 or use of medication, the percentage of 
treated hypertensive men did not change between 1987 and 1991, perhaps that 
physicians treated persons with only high blood pressure less frequently than 
persons with high blood pressure in combination with other risk factors for 
cardiovascular diseases. 
In the period 1987-1991, changes in blood pressure were minor in both 
men and women. Because none of the adjustments for possible confounding or 
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methodological aspects affected appreciably the trends in blood pressure, we 
conclude that the observed changes in blood pressure are probably real. The 
importance of the minor changes in systolic and diastolic blood pressure is 
unknown. Further research is needed to monitor future changes in blood pressure 
to see if the apparent divergent pattern of a decrease in systolic blood pressure 
and an increase in diastolic blood pressure are persistent and real. In 1987 the 
prevalence of hypertension based on an average of two blood pressure 
measurements was 8% in both men and women, and the prevalence of 
hypertension did not change between 1987 and 1991 in both sexes. This 
suggested a need for greater efforts at primary prevention by salt and alcohol 
restriction, weight control, and exercise. However, the percentage of treated 
hypertensive men and women decreased significantly in this period, probably 
because of a change in physicians' attitude toward treatment of hypertension. 
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DIFFERENCES IN THE ASSOCIATION BETWEEN 
ALCOHOL CONSUMPTION AND BLOOD PRESSURE BY 
AGE, GENDER AND SMOKING 
ABSTRACT 
The positive association between alcohol consumption and blood pressure is well-known. 
Little is known, however, about effect modification by age, gender, and smoking on the 
alcohol-blood pressure association. We used data of a cross-sectional study conducted in the 
Netherlands to investigate the association between alcohol consumption and blood pressure. 
Between 1987 and 1990, we examined about 30,000 men and women age 20-59 years. After 
adjustment for age, body mass index and smoking, we found that in men systolic and diastolic 
blood pressure increased by 0.9 and 0.6 mmHg, respectively, per daily drink. In women 
systolic and diastolic blood pressure were 2 mmHg and 1 mmHg higher in those who 
consumed 2 or more glasses per day, respectively, compared with nondrinkers. We observed 
a stronger association between alcohol and blood pressure in older men compared with 
younger men and in male and female smokers compared with nonsmokers. These data show 
that gender, age and smoking all are important effect modifiers of the alcohol-blood pressure 
relation. 
Edith M. van Leer, Jacob C. Seidell, Daan Kromhout. 
Epidemiology 1994;5:576-582 
41 
42 
Alcohol and blood pressure 
INTRODUCTION 
Many epidemiologic studies have observed a positive association between 
alcohol consumption and blood pressure in both men and women (1-8). These 
studies have reported both linear and nonlinear associations (J-shaped, U-shaped, 
or threshold). For both men and women it is not yet clear at which level of 
alcohol consumption blood pressure starts to increase. Furthermore, a difference 
in the relation between alcohol consumption and blood pressure among smokers 
and nonsmokers has been observed in three cross-sectional studies in Germany 
(9,10). Using data from a cross-sectional study conducted in the Netherlands 
among about 30,000 persons age 20-59 years (11), we investigated the shape of 
the association and the level of alcohol consumption at which systolic and 
diastolic blood pressure begin to increase in men and women. We also assessed 
effect modification and confounding of this association by age, smoking, degree 
of obesity, coffee consumption, physical activity during leisure time, and 
educational level. 
METHODS 
The Monitoring Risk Factor Project is an ongoing screening project that started 
in 1987. The project is carried out as part of the basic health services in 
Amsterdam, Doetinchem, and Maastricht. These towns are located in different 
parts of the Netherlands: Amsterdam, the capital city in the west; Doetinchem, 
a small town in the east; and Maastricht, a city in the south. Each year, a new 
random sample of men and women age 20-59 years was selected from the civil 
registry in each town. To obtain equal numbers in each age category, the 
sampling was stratified by gender and 5-year age classes. In Doetinchem and 
Maastricht, 400 persons were selected per stratum; in Amsterdam, 500 persons 
per stratum were selected because of the expected lower response rate. The 
overall response rate was about 54%, ranging from 46% in Amsterdam to 63% 
in Doetinchem. The response rate of women was higher than that of men (58% 
versus 51%). From 1987 through 1990, we examined about 30,000 men and 
women. 
In this study, blood pressure, height, and weight were measured, and 
blood samples were taken for total and high density lipoprotein cholesterol 
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determination. Blood pressure, with the subjects sitting, was measured using a 
random zero sphygmomanometer. Trained technicians, all of whom were 
instructed by one physician, carried out the measurements. The cuff (size 12 x 
23 cm) was applied to the left upper arm. A larger (15 x 33 cm) or a smaller (9 
x 18 cm) cuff was used when appropriate. The average body mass index in this 
population was relatively low (25 kg per m 2); a larger cuff was needed in only 
1.1 % of the subjects, and a smaller cuff was needed in 0.4 %. Systolic blood 
pressure was recorded at the appearance of sounds (first-phase Korotkoff), and 
diastolic blood pressure was recorded at the disappearance of sounds (fifth-phase 
Korotkoff). After the first measurement, the heart rate was measured for 30 
seconds, followed by a second blood pressure measurement. For these analyses, 
we used the average of the two blood pressure measurements. Weight was 
measured in subjects without shoes and wearing indoor clothing, after they 
emptied their pockets. Weight was recorded to the nearest 0.1 kg and height to 
the nearest 0.5 cm. The subject stood upright against the wall with the feet at 
a 45° angle. Body mass index was calculated as weight per height2 (kg per m 2). 
The subjects were asked to fill out a questionnaire from which information was 
obtained about demographic variables, presence and family history of 
cardiovascular diseases, presence of a number of other chronic diseases, current 
medication use, being on a prescribed diet, use of alcohol, smoking habits, 
physical activity, psychosocial factors, and, for women, reproductive history. 
We have estimated alcohol consumption from the following question: "Do 
you use alcohol?" with possible answers "never," "not anymore," "once in a 
while, but less than 1 glass a week," and "yes". We obtained the current 
consumption by asking for the number of glasses of beer, wine, port wine and 
liquor per week. For each alcoholic beverage, we assumed that one drink 
contains the same amount of alcohol (10 gm). We added the number of glasses 
of alcoholic beverages and divided by 7 to get the number of drinks per day. 
For men we divided alcohol consumption into 7 categories and, for women, into 
5 categories, because for men the range of alcohol consumption was larger than 
for women. We combined the group "once in a while, but less than 1 glass per 
week" with the category "less than 1 glass of alcohol intake per day" for both 
men and women. Average blood pressure was essentially the same in these 
categories. We excluded the group who responded "not anymore" from the 
analyses (276 men and 179 women) because they may have stopped drinking 
because of health problems (12). Subjects were also asked whether they were 
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treated for hypertension either by medication or prescribed diet. We excluded 
these men (n = 693) and women (n = 949) from the analyses. We also excluded 
pregnant women (n = 246) from the analyses. 
We divided age into 10-year age classes. We dichotomized cigarette 
smoking into smokers and nonsmokers, and physical activity during leisure time 
into inactive and active. Active was defined as exercise for at least 4 hours per 
week. For coffee consumption we used 4 categories: non-coffee drinkers and 
drinkers of regular coffee, decaffeinated coffee and other types of coffee. For 
education, we used categories of low, medium and high. For body mass index, 
we used two categories: <25 kg per m 2 and >25 kg per m 2. 
Reproducibility study 
In 1990, a subsample of about 450 men and 470 women age 20-60 years who 
also participated in 1989 was examined for a second time. The response rate in 
the second survey was 64%. This subpopulation did not differ from the total 
population with respect to age, blood pressure, and alcohol consumption. The 
purpose of this second examination was to estimate the within-person variation 
and the reproducibility of the blood pressure measurements and level of alcohol 
consumption. We used the within-person variation to estimate the unattenuated 
correlation coefficient of the relation between alcohol consumption and blood 
pressure. 
Nonresponse study 
In 1992, a nonresponse survey was carried out among 1,620 subjects who had 
been approached between August and December 1991 to assess possible 
selection bias (11). Responders and nonresponders were similar with respect to 
educational level, but the percentage of alcohol users was about 10% higher 
among responders than among nonresponders. In men, but not in women, the 
percentage of smokers was 15% higher among the nonresponders than among 
the responders. 
Statistical analyses 
We used linear regression analysis, with indicator variables for categories of 
alcohol consumption. We used two indicator variables for the different towns 
and three indicator variables for the different survey years, because mean blood 
pressure differed by town and survey year. We used indicator variables for 
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decade of age, and an indicator for smoking. The reference categories were for 
town, Amsterdam; survey year, 1987; age, 20-29 years; and nonsmoking. We 
entered body mass index in the model as a continuous variable. 
We analyzed the data by stratum of town and survey year to investigate 
whether the relation differed by these variables. We considered age, smoking, 
body mass index, education, coffee consumption, and physical activity during 
leisure time as potential effect-modifiers, using a linear regression model in 
which alcohol consumption was entered as a continuous variable. 
We calculated Pearson correlation coefficients to obtain an indicator for 
the reproducibility of the blood pressure measurements and alcohol consumption 
assessed in 1989 and 1990 in about 900 subjects. To estimate the effect of the 
two replicate measurements on the observed correlation between alcohol 
consumption and blood pressure, we calculated the unattenuated correlation 
coefficient (13). The observed correlation coefficient is lower than the 
unattenuated one because of within-person variability. The attenuation can only 
calculated for a Pearson correlation coefficient, relating variables with a normal 
distribution. Because alcohol consumption showed a skewed distribution, we 
applied a square root transformation. The correlation coefficients are adjusted 
for age, town, survey year, smoking, and body mass index. 
RESULTS 
About 92% of the men and about 73% of the women consumed alcoholic 
beverages. In men, we observed higher blood pressure levels in all six alcohol 
consumption categories compared with blood pressure in nondrinkers (Figure 1). 
We estimated that men who drank less than 1 drink per day had systolic 
pressures 2 mmHg (95% CI: 1.3-3.1) greater and diastolic pressures 0.6 mmHg 
(95% CI: -0.05 - 1.19) greater than nondrinkers. Men who drank more than 5 
drinks per day had systolic pressures 8 mmHg (95% CI: 6.7 - 9.2) greater and 
diastolic pressures 4 mmHg (95% CI: 3.4 - 5.2) greater than nondrinkers. 
Women who drank 2 or more drinks per day had higher systolic 2 mmHg (95% 
CI: 1.0 - 3.2) and diastolic blood pressures 1 mmHg (95% CI: 0.4 - 1.9) than 
nondrinkers (Figure 2). 
In every town and survey year, we observed a positive relation between 
alcohol consumption and blood pressure in both men and women. The relation 
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Figure 1. Mean systolic and diastolic blood pressure unadjusted and adjusted for town (three 
categories), year (four categories), age (four categories), smoking (two categories), and body 
mass index (continuous) by categories of alcohol consumption for men (n=12,609) age 20-59 
in the Monitoring Project on Cardiovascular risk Factors, 1987-1990. 
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Figure 2. Mean systolic and diastolic blood pressure unadjusted and adjusted for town (three 
categories), year (four categories), age (four categories), smoking (two categories), and body 
mass index (continuous) by categories of alcohol consumption for women (n= 14,010) aged 
20-59 in the Monitoring Project on Cardiovascular Risk Factors, 1987-1990. 
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between alcohol consumption and blood pressure did not differ much between 
the categories of body mass index and physical activity during leisure time 
(Table 1). In the different categories of educational level, the increase in blood 
pressure per glass of alcoholic drink was of the same order of magnitude. In 
women, however, we observed a somewhat weaker relation between alcohol 
consumption and diastolic blood pressure in the middle category of education 
than in the other categories. Among coffee drinkers, the relation between alcohol 
consumption and blood pressure was only consistent for drinkers of regular 
coffee. In the other categories of coffee consumption, the relation was less clear, 
possibly owing to small numbers. In both men and women, physical activity 
during leisure time, education, or coffee intake did not confound the relation 
between alcohol consumption and blood pressure. 
We observed a stronger relation between alcohol consumption and systolic 
blood pressure in older than in younger men (Tables 2 and 3). This pattern did 
not hold for women. The relation between alcohol consumption and diastolic 
blood pressure did not differ much by age category for men or for women. In 
both men and women, we observed a stronger relation between alcohol 
consumption and blood pressure in smokers than in nonsmokers (Tables 4 and 
5). 
The correlation coefficients for reproducibility were 0.87 for alcohol 
consumption, 0.73 for systolic blood pressure, and 0.63 for diastolic blood 
pressure for both men and women. For men, the adjusted observed correlation 
between alcohol consumption and systolic blood pressure was 0.12, and the 
unattenuated correlation was 0.13. For women, these correlations were 0.045 and 
0.051, respectively. For diastolic blood pressure, these correlations were 0.11 
and 0.12 in men and 0.027 and 0.032 in women, respectively. 
DISCUSSION 
The results of the present study were based on self-reported information about 
alcohol consumption and on the average of two blood pressure measurements 
measured at one occasion. Therefore, we estimated the unattenuated correlation 
between alcohol intake and blood pressure. The unattenuated correlations did not 
increase very much after taking the within-person variation into account because 
the correlations between the first and second measurements were high. 
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Table 1. Regression coefficients (B) and standard deviation (SD) of the relation between 
alcohol consumption (drinks/day) and blood pressure (mmHg) by strata of body mass index, 
education, physical activity and coffee consumption and the overall regression coefficient and 
standard deviation. 
variable men women 
Systolic blood Diastolic Systolic blood Diastolic 
pressure blood pressure blood 
pressure pressure 
B SD B SD B SD B SD 
Body mass index1 
<, 25 kg/m 2 0.95 0.09 0.54 0.06 0.64 0.13 0.30 0.09 
> 25 kg/m 2 0.90 0.09 0.60 0.06 0.52 0.21 0.28 0.13 
Education2 
low 0.93 0.08 0.61 0.05 0.80 0.14 0.49 0.09 
medium 0.97 0.14 0.53 0.10 0.40 0.25 0.06 0.17 
high 0.80 0.15 0.47 0.10 1.01 0.25 0.32 0.17 
Physical activity2 
inactive 0.88 0.10 0.59 0.07 0.60 0.17 0.34 0.12 
active 0.92 0.08 0.53 0.06 0.70 0.14 0.32 0.09 
Coffee 
consumption2 
no coffee 0.35 0.27 0.27 0.18 1.73 0.49 0.65 0.36 
regular 0.90 0.07 0.56 0.05 0.58 0.12 0.32 0.08 
decaffeinated 0.91 0.33 0.40 0.23 0.20 0.44 0.05 0.30 
other types 1.26 0.46 0.99 0.31 1.22 0.59 0.60 0.39 
Overall2 0.90 0.06 0.55 0.04 0.67 0.11 0.33 0.07 
Overall4 0.89 0.06 0.56 0.04 0.70 0.11 0.38 0.07 
1 adjusted for age, town, survey year, smoking 
2 adjusted for age, town, survey year, smoking, body mass index. 
3 adjusted for age, town, survey year, smoking, body mass index, coffee consumption, 
physical activity, education. 
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Table 2. Difference in mean blood pressure (mmHg)1 (and standard error) between each 
category of alcohol consumption (drinks/day) and nondrinkers by 10-year age group for men 
(the average blood pressure1 in nondrinkers in each age stratum is given in bold type) 
0 0.1-1.0 1.1-2.0 2.1-3.0 3.1-4.0 4.1-5.0 >5 
Age 
(years) 
Number 919 4,860 2,824 1,891 807 607 697 
SBP 
20-29 117.3 3.3 (0.8) 4.2 (0.9) 5.1 (1.0) 6.3 (1.3) 3.4 (1.4) 5.3 (1.5) 
30-39 118.2 1.8 (0.9) 1.9 (0.9) 3.1 (1.0) 4.5 (1.1) 5.8 (1.2) 5.9 (1.2) 
40-49 118.4 3.3 (0.9) 3.7 (0.9) 6.1 (1.0) 5.3 (1.1) 7.1 (1.2) 9.8 (1.1) 
50-59 125.3 0.9 (1.0) 2.8 (1.1) 3.2 (1.2) 3.5 (1.5) 5.9 (1.7) 8.9 (1.5) 
DBP 
20-29 72.1 0.6 (0.6) 0.2 (0.7) 1.0 (0.7) 3.2 (1.0) 1.1 (1.1) 2.7 (1.1) 
30-39 74.7 0.1 (0.7) 0.4 (0.7) 1.1 (0.7) 2.0 (0.9) 4.1 (0.9) 3.5 (0.9) 
40-49 76.9 1.4 (0.6) 1.2 (0.7) 2.5 (0.7) 2.5 (0.8) 3.3 (0.9) 5.3 (0.8) 
50-59 79.2 0.3 (0.6) 1.3 (0.7) 1.2 (0.7) 1.4 (0.9) 3.5 (1.0) 4.7 (0.9) 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
1 adjusted for town, survey year, smoking, body mass index. 
In the literature, there is no agreement on the shape of the association between 
alcohol consumption and blood pressure (14-16). Specifically, at the lower end 
of alcohol consumption it is not clear whether or not a linear relation exists. 
Most studies have reported elevated blood pressure in subjects consuming 3 or 
more glasses per day, in comparison with nondrinkers. Adjustment for age, 
smoking, and body mass index has been found to affect the shape of the 
association between alcohol consumption and blood pressure (17). 
Women in this population drank more wine and less beer and spirits, 
which could explain the different findings for men and women. Some studies 
have suggested that the blood pressure elevating effect of wine is lower than the 
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Table 3. Difference in mean blood pressure (mmHg)1 (and standard error) between each 
category of alcohol consumption (drinks/day) and nondrinkers by 10-year age group for 
women (the average blood pressure1 in nondrinkers in each age stratum is given in bold type) 
0 0.1-1.0 1.1-2.0 2.1-3.0 > 3 
AGE (years) 
number 2,638 8,390 1,879 684 417 
SBP 
20-29 110.7 0.7 (0.5) 0.9 (0.5) 1.9 (0.8) -0.7 (1.4) 
30-39 110.3 0.6 (0.5) 0.8 (0.6) 1.0 (0.9) 3.4 (1.1) 
40-49 115.6 -0.03 (0.6) 0.3 (0.8) 2.5 (1.0) 4.6 (1.2) 
50-59 112.5 0.4 (0.7) -0.3 (0.9) 3.4 (1.4) 3.9 (1.7) 
DBP 
20-29 69.3 0.5 (0.4) 0.6 (0.6) 1.1 (1.1) 1.1 (1.4) 
30-39 70.8 0.2 (0.4) 0.02 (0.5) 0.4 (0.7) 2.8 (0.8) 
40-49 74.2 0.2 (0.4) 0.2 (0.5) 1.2 (0.7) 2.1 (0.8) 
50-59 77.0 0.3 (0.4) 0.0 (0.5) 2.1 (0.8) 1.6 (1.0) 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
1 adjusted for town, survey year, smoking, body mass index. 
effect of beer and spirits (2,3). Two randomized controlled studies have shown 
a direct effect of alcohol consumption on blood pressure (17). The mechanisms 
by which alcohol consumption may lead to elevated blood pressure are still 
uncertain, however. 
Many studies have reported conflicting results on the association between 
alcohol intake and blood pressure in different age categories. Some studies have 
reported stronger associations between alcohol consumption and blood pressure 
in younger subjects, (10,18-20) and other studies have observed these 
associations in older subjects (2,3,9,21-23). 
To our knowledge, very few studies have investigated the possibility of 
a modifying effect of smoking on the blood pressure-alcohol association. In the 
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Table 4. Difference in mean blood pressure (mmHg)1 (and standard error) between each 
category of alcohol consumption (drinks/day) and nondrinkers for smoking and nonsmoking 
men (the average blood pressure1 in nondrinkers in each stratum of smoking is given in bold 
type) 
0 0.1-1.0 1.1-2.0 2.1-3.0 3.1-4.0 4.1-5.0 > 5 
Smoking 
number 326 1,652 1,104 900 408 330 425 
SBP 118.0 3.5 (0.8) 4.9 (0.8) 6.5 (0.8) 7.2 (1.0) 7.7 (1.0) 10.2 (1.0) 
DBP 74.2 1.5 (0.5) 1.8 (0.6) 2.6 (0.6) 3.8 (0.7) 4.9 (0.7) 5.6 (0.7) 
Nonsmoking 
number 593 3210 1720 991 399 279 272 
SBP 121.2 1.6 (0.6) 2.1 (0.6) 3.1 (0.7) 3.1 (0.8) 4.9 (0.9) 6.0 (0.9) 
DBP 77.0 0.1 (0.4) 0.2 (0.4) 0.9 (0.5) 1.0 (0.6) 2.0 (0.7) 3.3 (0.7) 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
1 adjusted for age, town, survey year, body mass index. 
Framingham Study lower blood pressure levels were observed in smokers 
compared with nonsmokers, but this seemed to be due to the lower body 
weights (6).In an Australian study of men, mean diastolic blood pressure was 
lower in smokers compared with nonsmokers even after adjustment for age and 
body mass index (24). In the Nurses' Health Study, risks for hypertension did 
not differ between smokers and nonsmokers (18). The observed interaction 
between alcohol consumption and smoking in the present study for both men 
and women has also been found in the MONICA Augsburg Survey (10). In this 
study, it was observed that effect modification by smoking was stronger in men 
than in women. A possible explanation for the interaction of smoking on the 
association between alcohol intake and blood pressure may be that smoking is 
associated with a change in pattern of body fat distribution, which results in a 
higher waist-to-hip circumference ratio in smokers compared with nonsmokers 
(25). A higher waist-to-hip circumference ratio is correlated with 
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hypermsulinernia and hypertension (26). It is possible that smoking influences 
blood pressure by changing the body fat distribution (27). 
Table 5. Difference in mean blood pressure (mmHg)1 (and standard error) between each 
category of alcohol consumption (drinks/day) and nondrinkers for smoking and nonsmoking 
women (the average blood pressure1 in nondrinkers in each stratum of smoking is given in 
bold type) 
0 0.1-1.0 1.1-2.0 2.1-3.0 >3 
Smoking 
number 900 
SBP 114.0 
DBP 71.9 
Nonsmoking 
number 1,738 
SBP 115.4 
DBP 73.6 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
1 adjusted for age, town, survey year, body mass index. 
Several studies investigated the influence of body mass index on the alcohol-
blood pressure association but did not draw clear conclusions (1,24). In the 
present study, we did not observe an interaction between alcohol consumption 
and body mass index. This finding differs from those of the Nurses' Health 
Study, (18) in which a stronger association between the risk for hypertension 
and alcohol consumption was observed for women with a body mass index <29 
kg per m 2 compared with women with a body mass index >29 kg per m 2. 
3,092 
0.8 (0.5) 
0.7 (0.3) 
5,300 
0.3 (0.4) 
0.1 (0.2) 
952 
1.0 (0.6) 
0.7 (0.4) 
927 
0.1 (0.5) 
-0.2 (0.4) 
394 
3.1 (0.8) 
1.6 (0.5) 
290 
1.2 (0.8) 
0.9 (0.6) 
297 
4.3 (0.9) 
2.8 (0.6) 
120 
3.1 (1.2) 
1.2 (0.8) 
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DIETARY CALCIUM, POTASSIUM, MAGNESIUM AND 
BLOOD PRESSURE IN 20,921 MEN AND WOMEN AGED 
20-59 YEARS IN THE NETHERLANDS 
ABSTRACT 
The relation between blood pressure and dietary calcium, potassium and magnesium and the 
combined effect of these minerals on blood pressure was studied in 20,921 Dutch men and 
women aged 20-59 years. Food intake was measured by a food frequency questionnaire. After 
adjustment for age, body mass index, alcohol and energy intake an inverse association was 
observed between blood pressure and dietary potassium, and magnesium, in both men and 
women. Dietary calcium was inversely related to systolic blood pressure in women and with 
diastolic blood pressure in both men and women. The relation between magnesium intake and 
blood pressure was stronger than those between blood pressure and intakes of potassium and 
calcium. Men and women who consumed a diet with intakes in the upper tertiles of all three 
minerals had a lower systolic and diastolic blood pressure compared to those who had intakes 
in the lower tertiles (men: SBP: -1.7 ± 0.7 mmHg, DBP: -2.1 ± 0.4 mmHg, women: SBP: -2.0 
± 0.7 mmHg, DBP: -1.7 ± 0.4 mmHg). These results suggest that diets rich in calcium, 
potassium and magnesium are associated with lower blood pressure. 
Edith M. van Leer, Jacob C. Seidell, Daan Kromhout. 
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INTRODUCTION 
In most cross-sectional studies an inverse association between dietary calcium 
and blood pressure has been reported (1,2). However, the results of prospective 
studies were inconsistent (3,4) and the majority of intervention studies have not 
supported the inverse association between calcium supplementation and blood 
pressure (1,5). Some observational studies have observed an inverse association 
between blood pressure and dietary potassium (6-11) while others have not 
observed such an association (4,12-15). Intervention studies have suggested that 
potassium supplementation may be an effective therapy for producing a modest 
decrease in blood pressure (16), particularly in patients who consume large 
quantities of sodium (17). In most observational studies an inverse relation 
between dietary magnesium and blood pressure has been observed 
(4,8,14,15,18). However, the results of intervention studies were inconsistent (1). 
In observational studies the intake of calcium, potassium and magnesium are 
highly correlated. Therefore, in the present cross-sectional study besides the 
relation between blood pressure and dietary calcium, potassium and magnesium 
also the combined effect of the intake of the three minerals on blood pressure 
has been investigated in more than 20,000 men and women aged 20-59 years in 
The Netherlands. 
METHODS 
The Monitoring Project on Cardiovascular Risk Factors is a screening project 
which has been performed between 1987 and 1991. The project is carried out 
in basic health services in Amsterdam, Doetinchem and Maastricht. These towns 
are located in different parts of the Netherlands: Amsterdam, the capital city in 
the west; Doetinchem, a small town in the east and Maastricht a town in the 
south. Each year a new random sample of men and women aged 20-59 years 
was selected in each city. The random sample was selected from the civil 
registry in each town. To obtain equal numbers in each age category, the sample 
was stratified according to gender and five year age classes. In Doetinchem and 
Maastricht 400 persons were selected per stratum, in Amsterdam 500 because 
of the lower response in Amsterdam. The overall response rate was about 50 per 
cent for men and 57 per cent for women. From 1987 till 1991 about 36.000 men 
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and women were examined. 
In this study blood pressure, height and weight were measured and blood 
was taken for total and high density lipoprotein cholesterol determination. Blood 
pressure was measured with the subject in sitting position using a random zero 
sphygmomanometer. The measurements were carried out by trained technicians 
who were all instructed by the same physician. The cuff (size 12 x 23 cm) was 
applied to the left upper arm. In about 1.5 per cent of the subjects a larger (15 
x 33 cm) or a smaller (9 x 18 cm) cuff was used when appropriate. Systolic 
blood pressure was recorded at the appearance of sounds (first-phase Korotkoff) 
and the diastolic blood pressure was recorded at the disappearance of sounds 
(fifth-phase Korotkoff). After the first measurement heart rate was measured for 
30 seconds followed by a second blood pressure measurement. For the analyses 
the average of the two blood pressure measurements was used. Weight was 
measured in subjects without shoes and wearing indoor clothing and after 
subjects emptied their pockets. Weight was recorded to the nearest 0.1 kg and 
height to the nearest 0.5 cm. The subjects stood upright against the wall with the 
feet at a 45° angle. Body Mass Index (BMI) was calculated as weight/height2 
(kg/m2). The subjects were asked to fill out a questionnaire from which 
information was obtained about educational level, current medication use, being 
on a prescribed diet, use of alcohol and of calcium supplements. 
The usual dietary intake was assessed by using a short (70 food items) 
self-administered semi-quantitative food frequency questionnaire (19). The 
questionnaire was constructed to be able to assess the intake of energy and 
nutrients of interest in cardiovascular disease epidemiology. The food frequency 
questionnaire was validated in a subsample of 203 subjects. In this sample the 
food and nutrient intake was assessed both by the food frequency questionnaire 
and a cross-check dietary history in which information about the food intake was 
obtained from the last 14 days. The cross-check dietary history was carried out 
in 1989 by two experienced dieticians. The nutrient content of the diet was 
calculated using the computerized version of the Netherlands (NEVO) food 
table, containing about 1300 foods (20). The magnesium content of the diet was 
collected from different sources (21). The reproducibility of the food frequency 
questionnaire was assessed by repeating the administration of this questionnaire 
with a one-year interval in 925 subjects. 
Subjects (n=2601) treated for hypertension either by medication or 
prescribed diet were excluded from the analyses. Pregnant women (n=306) were 
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also excluded from the analyses. Subjects who were vegetarian (n=1046), 
macrobiotic (n=127), antroposophic (n=57) or seventh-Day adventists (n=48) 
were also excluded from the analyses. This was done because the food items 
(such as potatoes, rice and legumes) used by these subjects were not included 
in the food frequency list. Subjects who have 1 or more missing food items in 
the food frequency list were excluded from the analysis (n=3,266) because it 
was not possible to estimate their nutrient intake accurately. In order to be able 
to exclude subjects who overreport or underreport their energy intake the basal 
metabolic rate (BMR) was estimated from WHO equations (22). In the present 
study subjects with an energy intake of less than 1 times BMR (n=1570) or an 
energy intake of more than 2.1 times BMR for men or 1.82 times for women 
(n=7652) were excluded from the analyses. These limits were chosen because 
it is unlikely that an energy intake below the lower limit and above the upper 
limit are real. After excluding these subjects 11,679 men and 9,224 women were 
left for analysis. In the reproducibility study pregnant women and subjects 
treated for hypertension either by medication or prescribed diet were excluded 
from the analyses. In the reproducibility study 834 subjects were left for 
analysis. 
Age was divided in 10-year age classes. Alcohol consumption was divided 
into three categories: 0 g/day, >0-<20 g/day and >20 g/day. Calcium supple-
mentation was divided in users and non-users. The cut-off points for low and 
high mineral intake were based on tertiles. For men: tertile cut-off points were 
1023 and 1393 mg/day for calcium, 3923 and 4673 mg/day for potassium and 
384 and 469 mg/day for magnesium. For women: tertile cut-off points were 899 
and 1229 mg/day for calcium, 3417 and 4070 mg/day for potassium and 327 
and 390 mg/day for magnesium. Mineral intake was divided in 8 categories 
which were made of all combinations of tertiles of the three elements. 
A non-response study was performed among 1620 subjects who had been 
invited for the first time between august and december 1991 (23). In april/may 
1992 they were approached for a second time by telephone (75 per cent) or 
those who did not have a telephone by mail (25 per cent). Information of 61 % 
of the non-participants could be obtained, 23 % could not be reached and 16 % 
refused to participate. Information included educational level, use of alcohol, 
smoking habits, weight and height. 
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Statistical analysis 
Pearson correlation coefficients between the nutrients were calculated to 
diagnose potential problems with collinearity. The food frequency questionnaire 
was compared with a dietary history. Pearson correlation coefficients were used 
to compare the intake of calcium, potassium and magnesium from the food 
frequency questionnaire with the intake from the dietary history in 203 subjects. 
Pearson correlation coefficients were also calculated as indicators for the 
reproducibility of the intake of calcium, potassium, magnesium and the blood 
pressure measurement assessed in 1989 and 1991. 
Regression analysis was used to examine the association between blood 
pressure and dietary calcium, potassium and magnesium. The minerals were 
entered separately in the model because of multi-collinearity. The analyses were 
adjusted for age, town, survey year, body mass index, alcohol and energy intake. 
Because dietary magnesium and fiber were strongly correlated, the effect of 
dietary fiber on the association between blood pressure and magnesium was also 
studied. Body mass index and energy intake were entered in the model as 
continuous variables. Dummy variables for the categories of age, town, survey 
year and alcohol intake were entered to the model. This was done because mean 
blood pressure was different between the towns and survey years. The relation 
between blood pressure and age was not linear and alcohol intake showed a 
skewed distribution. These categories were chosen because previously we 
observed that blood pressure increased at an intake of about 20 g/day in both 
men and women (24). The reference categories were for age: 20-29 years, town: 
Amsterdam, survey year: 1987, alcohol consumption: non-drinkers. 
Dietary calcium, potassium and magnesium were strongly correlated with 
each other. Therefore, the combined effect of these three minerals on blood 
pressure was studied. To estimate the difference in systolic and diastolic blood 
pressure between persons consuming a diet high in calcium, potassium and 
magnesium compared to persons consuming a diet low in these minerals 
regression analysis was also used. Seven dummy variables for the combination 
of tertiles of the high mineral intake were entered in the regression model and 
compared to the combination of the lower tertiles. Regression analysis was also 
used to estimate the difference in systolic and diastolic blood pressure in the 
category calcium supplementation users compared with the category never users. 
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RESULTS 
Table 1 shows mean blood pressure, body mass index, age, energy, alcohol and 
mineral intake in men and women aged 20-59 years. Average body mass index 
was about the same for both men and women. Blood pressure and energy, 
alcohol and mineral intake were higher in men than in women. 
Table 1. Blood pressure, body mass index, age, energy, alcohol and mineral intake among 
men and women aged 20-59 years in the Monitoring Project on Cardiovascular Disease Risk 
Factors. 
Variable Men Women 
Mean (sd) Mean (sd) 
N 11,697 9,224 
systolic blood pressure (mmHg) 123.7 (13.4) 116.5 (14.7) 
diastolic blood pressure (mmHg) 77.9 (9.8) 74.3 (9.8) 
body mass index(kg/m2) 25.3 (3.2) 25.2 (4.1) 
age (years) 41.4 (10.7) 41.5 (11.2) 
energy (Kcal/day) 2793 (508) 2088 (317) 
alcohol (g/day)1 20 (17) 14 (11) 
calcium (mg/day) 1237 (441) 1082 (374) 
potassium (mg/day) 4332 (892) 3761 (746) 
magnesium (mg/day) 429 (99) 359 (74) 
1 mean alcohol intake among alcohol users. 
The correlation coefficients between calcium and potassium intake were 0.64 in 
men and 0.65 in women, 0.53 in men and 0.54 in women for calcium and 
magnesium intake and 0.84 in both men and women for potassium and 
magnesium intake. The correlation coefficient between the food frequency 
questionnaire and the dietary history data varied in men between 0.47 for 
potassium and 0.64 for magnesium. In women the coefficients varied between 
0.55 for calcium and 0.72 for magnesium. The correlation coefficient between 
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the two replicate measurements varied in men and women between 0.63 and 
0.76 for calcium, potassium, magnesium, systolic and diastolic blood pressure. 
All these coefficients were significant. 
For both men and women an inverse significant association was observed 
between blood pressure and dietary potassium and magnesium (table 2). In men, 
the association between systolic blood pressure and dietary calcium was not 
significant while in women systolic blood pressure was significantly inversely 
associated with dietary calcium. In both men and women the association 
between diastolic blood pressure and dietary calcium was significant. 
Table 2. Regression coefficients' (95% confidence intervals between brackets) for the relation 
between blood pressure (mmHg) and calcium, potassium and magnesium (mg/day) in 20,921 
men and women aged 20-59 years. 
Men Women 
Systolic blood pressure 
Calcium -0.0003 (-0.0009, 0.0003) -0.0010 (-0.0018, 0.0002) 
Potassium -0.0008 (-0.0011, -0.0005) -0.0006 (-0.0010, -0.0002) 
Magnesium -0.0081 (-0.0011, -0.0050) -0.0095 (-0.0140, -0.0050) 
Diastolic blood pressure 
Calcium -0.0007 (-0.0011, -0.0003) -0.0006 (-0.0011, -0.0001) 
Potassium -0.0007 (-0.0008, -0.0004) -0.0005 (-0.0008, -0.0002) 
Magnesium -0.0069 (-0.0090, -0.0048) -0.0068 (-0.0098, -0.0038) 
1 adjusted for age, town, survey year, body mass index, alcohol and energy intake. 
The association between blood pressure and dietary potassium and magnesium 
was stronger than the association between blood pressure and dietary calcium. 
Both systolic and diastolic blood pressure were inversely related with dietary 
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fiber but after adjustment for dietary magnesium this association disappeared. 
When subjects who overreported or underreported their energy intake were not 
excluded from the analyses the associations between blood pressure and dietary 
calcium, potassium and magnesium were weaker except for the relation between 
systolic blood pressure and dietary calcium in men (regression coefficient = 
-0.0005; 95% CI = -0.0010, 0). 
In both men and women mean systolic and diastolic blood pressure were 
significantly lower in the upper tertiles of calcium, potassium and magnesium 
intake compared to those in the lower tertiles (figure 1 and 2). The difference 
in both systolic and diastolic blood pressure between the two categories was 
about 2 mmHg. In the category with high mineral intake the average intake per 
130 
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115 
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mean systolic blood pressure (mmHg) 
N - 1953 m e n N - 1882 N = 1554 w o m e n N = 1509 
low ca/k/mg high ca/k/mg 
Figure 1. Mean systolic blood pressure adjusted for age, town, survey year, body mass index, 
alcohol and energy intake in persons with respectively low and high intakes of calcium, 
potassium and magnesium. Difference in systolic blood pressure between the two categories 
(mean and between the brackets 95% confidence interval of the regression coefficient between 
brackets). 
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day was 1800 mg calcium, 5500 mg potassium and 550 mg magnesium in men 
and 1600 mg calcium, 4800 mg potassium and 450 mg magnesium in women. 
The average intake per day in the reference category was 740 mg calcium, 3200 
mg potassium and 300 mg magnesium in men and 650 mg calcium, 2800 mg 
potassium and 265 mg magnesium in women. Mean blood pressure in the other 
combinations of tertiles did not differ significantly from the reference category, 
except diastolic blood pressure in the category low calcium, low potassium and 
high magnesium in women. For most combinations the number of subjects was 
relatively small. 
mean diastolic blood pressure (mmHg) 
80 I 
N • 1953 men N - 1882 N » 1554 women N - 1509 
low oa/k/mg Li high ca/k/mg 
Figure 2. Mean diastolic blood pressure adjusted for age, town, survey year, body mass 
Index, alcohol and energy intake in persons with respectively low and high intakes of 
calcium, potassium and magnesium. Difference in diastolic blood pressure between the two 
categories (mean and between brackets 95% confidence interval of the regression coefficient). 
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The percentage of subjects using calcium supplementation was 2.6 % in men 
and 9.5 % in women. Only in women who used calcium supplements systolic 
blood pressure was significantly lower compared to women who never used 
supplements (table 3). In both men and women diastolic blood pressure did not 
differ significantly between users and non-users of calcium supplements. 
Table 3. Differences in mean blood pressure1 (95% confidence interval between brackets) 
between calcium supplementation users (299 men and 872 women) and never users (11,395 
men and 8,351 women) 
Men Women 
Mean difference mean difference 
systolic blood pressure (mmHg) -0.77 (-2.28, 0.74) -1.40 (-2.38, -0.51) 
diastolic blood pressure (mmHg) -0.05 (-1.08, 1.00) -0.26 (-0.76, 0.49) 
1 adjusted for age, town, survey year, body mass index, dietary calcium, alcohol and energy 
intake 
DISCUSSION 
In the present study inverse associations were observed between blood pressure 
and dietary potassium and magnesium with the exception of calcium. The 
strongest association was observed for dietary magnesium. Also the combined 
effect of these minerals was studied because it was not possible to study the 
independent linear associations between dietary potassium, magnesium and 
calcium and blood pressure because of problems with multi-collinearity. Mean 
systolic and diastolic blood pressure in the upper tertiles of calcium, potassium 
and magnesium was about 2 mmHg lower than in the lower tertiles of these 
minerals in both men and women. 
In the present study the response was about 54 %. Educational level is a 
potential confounder of the relation between mineral intake and blood pressure. 
However, among responders, adjustment for educational level did not affect the 
observed relations. Also responders and non-responders were similar with 
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respect to educational level (23). Subjects who were on a prescribed diet or used 
medication for high blood pressure were excluded because these could have 
affected the observed associations. Subjects who over or underreported their 
energy intake were excluded because these biases weakened the associations. 
In the present study food intake was measured by a short semi-
quantitative food frequency questionnaire because in this large study it was not 
possible to measure food intake by an extensive dietary survey method. The 
calcium, potassium and magnesium intake calculated from the food frequency 
questionnaire were compared with the intake of these minerals estimated with 
the dietary history method. The correlation coefficients between calcium, 
potassium and magnesium intake from the food frequency method and the 
dietary history varied between 0.5 and 0.7. These correlation coefficients are in 
the same order of magnitude as those observed in other studies in which a food-
frequency questionnaire is compared with other dietary assessment methods such 
as dietary history, food records, 24-hour-recall (25-28). Ideally dietary survey 
methods with independent error structures should be compared. In all these 
validation studies this prerequisite is not fulfilled because the usually food intake 
is estimated by or with the same person. Also the reproducibility of the food 
frequency questionnaire was assessed. The correlation coefficients varied 
between 0.6 and 0.8. In other reproducibility studies similar coefficients were 
obtained (28). These results suggest that the reproducibility and validity of the 
dietary minerals estimated with the food frequency questionnaire was 
comparable with those observed by other investigators. 
Many cross-sectional studies suggested that calcium intake is inversely 
associated with blood pressure (1,2). In the present study calcium was inversely 
related to diastolic blood pressure in men and to both systolic and diastolic 
blood pressure in women. However, the effect of dietary calcium on blood 
pressure was small. Blood pressure did not differ between users of calcium 
supplements and never users with the exception of systolic blood pressure in 
women, that was lower in users compared with never users. In randomized 
controlled trials no effect of oral calcium supplementation on blood pressure was 
observed (5). These results suggest that dietary calcium is not independently 
associated with blood pressure. 
An inverse association between potassium intake and blood pressure has 
been observed in both men and women in the present study. This association 
was found in several other observational studies (6-11), however, in some 
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studies such a relationship has not been observed (4, 12-15). A meta-analysis of 
19 clinical trials indicated that oral potassium supplementation significantly 
lowered systolic and diastolic blood pressure (16). The results of both 
observational studies and clinical trials suggest that potassium supplementation 
can play a role in blood pressure lowering. 
In most observational studies an inverse relation between magnesium 
intake and blood pressure has been observed (4,8,14,15,18). The results of the 
present study are in agreement with the results of these studies. The effect of 
magnesium on blood pressure has also been investigated in clinical trials (1). 
These trials do not unanimously support a contributing role for magnesium in 
the regulation of blood pressure. The relation between dietary magnesium and 
blood pressure needs further study. 
In the present study the relation between blood pressure and dietary fiber 
disappeared after adjustment for dietary magnesium. Also in the Nurses Health 
Study no association between hypertension and dietary fiber has been observed 
after adjustment for dietary magnesium (14) while in the US male health 
professionals follow-up study an inverse association has been observed between 
hypertension and dietary fiber after adjustment for dietary magnesium (4). In a 
cross-sectional study in normotensive males an inverse association has been 
observed between blood pressure and only fruit fiber after adjustment for 
magnesium (12). A definite statement about the independent effects of dietary 
fiber and magnesium on blood pressure can therefore not be made. 
The results of the present study suggest that men and women consuming 
a diet high in calcium, potassium and magnesium had 2 mmHg lower systolic 
and diastolic blood pressure levels compared to men and women consuming a 
diet low in calcium, potassium and magnesium. A reduction in diastolic blood 
pressure of 2 mmHg may lead to about 15 % less stroke and about 5 % less 
coronary heart disease (29). The evidence of observational and supplementation 
studies suggests that a high intake of potassium and magnesium may be of 
importance for the prevention of major public health issues such as coronary 
heart disease and stroke. The intake of calcium seems to be less important 
because hardly no effect of calcium supplementation on blood pressure was 
observed. Magnesium intake can be increased by increasing the intake of whole 
wheat bread, brown rice, legumes, potatoes and nuts. Potassium intake can be 
increased by increasing the intake of vegetables and fruit. Changes in blood 
pressure by using this type of a diet are small but can have important health 
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benefits if applied to the population as a whole (30). 
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BLOOD PRESSURE AND MORTALITY IN 50,000 MEN AND 
WOMEN IN THE NETHERLANDS DURING A 12-YEAR 
FOLLOW-UP. THE NETHERLANDS CONSULTATION 
BUREAU PROJECT ON CARDIOVASCULAR DISEASES. 
ABSTRACT 
Objective: To study the association between blood pressure and mortality from coronary heart 
disease (CHD), cerebrovascular accidents (CVA), cardiovascular diseases (CVD) and all 
causes in the Netherlands. Interaction with obesity and smoking was analyzed as well. 
Method: A single blood pressure measurement was obtained in 50,000 men and women aged 
30-54 years at baseline. Average follow-up time was 12 years. 
Results: Systolic blood pressure levels of 140 mmHg or higher, or diastolic blood pressure 
levels of 90 mmHg or higher, were strongly associated with total and cardiovascular mortality 
in both sexes. In men both the absolute and relative risks were higher than in women. In men 
the population attributable risks were 18% for total mortality, 28% for CHD and 58% for 
CVA mortality. For women these percentages were 7%, 19% and 27%, respectively. No 
significant interactions were observed with obesity and smoking. It was estimated that a 6-
mmHg decrease in diastolic blood pressure would result in a mortality reduction of about 41% 
for CVD and 28% for all causes in men, and 29% and 12% in women. 
Conclusion: high blood pressure is strongly related to CVD and all cause mortality in both 
men and women, but the public health impact of blood pressure reduction is higher in men 
than in women. 
Edith M. van Leer, W.M.Monique Verschuren, Jacob C. Seidell, Daan Kromhout 
Submitted 
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INTRODUCTION 
In prospective studies blood pressure has been shown to be a strong predictor 
of mortality from coronary heart disease (CHD), cerebrovascular diseases 
(CVA), cardiovascular diseases (CVD) and all causes (1-7). Only a few 
prospective studies included both sexes and analyzed possible differences in the 
association between blood pressure and mortality in men and women (5,8,9). 
In addition to the effect of gender on the association between blood 
pressure and mortality we also investigated potential effect modification of 
smoking and obesity on this association. Several prospective studies have 
reported a more pronounced risk of dying from CHD, CVD and all causes when 
hypertension was associated with leanness rather than obesity (10-13) while 
others did not (14-16). In the MRFIT Study and British Regional Heart Survey 
the risk of CHD was higher among hypertensive men who were smokers 
compared to nonsmokers (17-18). These results suggest that the relation between 
hypertension and mortality from all causes, CHD, CVA and CVD may be 
different between hypertensive smokers and nonsmokers. 
This is the first prospective study in The Netherlands in which the relation 
between blood pressure and cause-specific mortality has been studied in about 
50,000 Dutch men and women aged 30-54 years. In this paper the associations 
between systolic and diastolic blood pressure and mortality from CHD, CVA, 
CVD and all causes will be reported. Special attention was paid to whether the 
shape and strength of the association differ between men and women. In 
addition to the relative risks, the population-attributable risks were calculated for 
different degrees of hypertension. Also effect modification by obesity and 
smoking was assessed. 
METHODS 
The Consultation Bureau Project on Cardiovascular Diseases was carried out in 
five towns in the Netherlands: Amsterdam, Doetinchem, Maastricht, Leiden and 
Tilburg. The examinations were carried out between 1974 and 1980. Different 
birth cohorts were selected in different towns. Names and addresses of the 
participants were obtained from the municipal registries. The response rate 
ranged from 70% to 80% (19) The study was aimed at the age group of around 
40 years. The age range was 30 to 54 years, about two-third of the respondents 
was between 35 and 45 years. In this period about 50,000 men and women were 
examined. 
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In the present study blood pressure, height and weight were measured and 
non-fasting blood samples were taken for total cholesterol determination (20). 
Blood pressure was measured once while subjects were seated with a random 
zero sphygmomanometer. The measurements were carried out by trained 
technicians who had received detailed instructions on the use the of the 
sphygmomanometer. The cuff (size 12 x 23 cm) was applied to the right upper 
arm. Systolic blood pressure was recorded at the appearance of sounds (first-
phase Korotkoff) and the diastolic blood pressure was recorded at the 
disappearance of sounds (fifth-phase Korotkoff). Weight was measured in 
subjects without shoes and wearing indoor clothing, after they emptied then-
pockets. Body mass index was calculated as weight/height (kg/m2). Serum total 
cholesterol was determined according to the Huang method (21). The 
participants filled out a questionnaire in which information was obtained about 
current smoking habits, current use of medication for high blood pressure, 
history of hypertension, diabetes mellitus and cardiovascular diseases. 
The mortality follow-up was started in 1986 and completed in 1993. The 
names and addresses of all participants were retrieved from the archives, and 
entered into the computer. The vital status was obtained from the municipal 
registry in the town of residence at the time of examination. The follow-up was 
considered completed when the respondent was identified at his/her present 
address or if the date of death of the respondent was known. Censor date was 
the date at which the information was obtained from the municipal registry (for 
the living) or the date of death. If a person had moved with unknown 
destination, the date at which the person was not living anymore in the town 
was used as censor date. From 49,202 of the 50,887 persons examined, the 
names and addresses were still present in the archives. For 49,018 of these 
49,202 persons mortality follow-up was successfully completed. A total of 1319 
persons had died during the follow-up. From 1288 the primary cause of death 
was obtained from the Central Bureau of Statistics, while from 31 persons who 
died outside the Netherlands, such information could not be obtained. The 
underlying causes of death were coded according to the 9th Revision of the 
International Classification of Diseases (ICD). For deaths that had occurred 
before January 1st 1979 (n=89), the 8th Revision was used. All codes from ICD-
8 remained in the same category when defined according to ICD-9. For the 
present analyses the following subgroups were used CHD ICD-codes 410-414, 
CVA ICD-codes 430-438, CVD ICD-codes 401-448. 
Systolic and diastolic blood pressure were divided in categories of 10 
mmHg. Participants were also classified into categories of hypertension 
according to the WHO guidelines (1). To study effect modification participants 
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were classified into the category normotensive and hypertensive defined as 
systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg 
and/or use of antihypertensive medication. The cut-off points for body mass 
index was 25 kg/m2. Smoking was dichotomized into smokers and current 
nonsmokers. Interaction was studied for CHD and CVA mortality and not for 
combinations of different causes of death. 
Statistical analyses 
Statistical analysis was carried out using the SAS program (version 6.1). All 
analyses were carried out separately for men and women. Mortality rates were 
calculated per category of 10 mmHg systolic and diastolic blood pressure and 
according to the WHO guidelines and for the normotensives and hypertensives 
per strata of body mass index and smoking (1). The relative risks were estimated 
by using the Cox proportional hazards models (22). The results were adjusted 
for age, serum cholesterol, body mass index and smoking. The Chi-square test 
for trend was used to test linearity. Age, serum cholesterol and body mass index 
were entered as continuous variables in the model. Current smoking was 
dichotomized into smoking and nonsmoking. Nonsmoking was the reference 
category. Population-attributable risks (PAR) were calculated for the categories 
of hypertension using normotension as the reference category (23). 
RESULTS 
Average follow-up time of the persons enrolled in the study was 12 years (Table 
1). Average age was 39 years in both men and women. Blood pressure was 
higher in men than in women. Average body mass index was similar in both 
sexes. About two-third of the men and about half of the women were smokers. 
Twice as much women were treated for hypertension than men. 
Figure 1 and 2 show that both systolic and diastolic blood pressure were 
associated with mortality from CHD, CVA, CVD and all causes in both men 
and women. In men the test for linear trend was significant for both systolic and 
diastolic blood pressure for all endpoints. In women the test for trend was not 
significant for the association between systolic blood pressure and CVA 
mortality and for diastolic blood pressure and CHD mortality. The curves for 
CVA mortality flatten what may be due to the small number of cases in the 
systolic blood pressure category >170 mmHg. The absolute and relative risks for 
CHD, CVA, CVD and total mortality were higher in men than in women. 
In men mild as well as severe hypertension as defined by the WHO were 
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Table 1. Average age, follow-up time, blood pressure, body mass index, percentage of 
cigarette smokers and percentage of users of medication for high blood pressure. 
Variable Men Women 
mean (sd) mean (sd) 
N 23,389 25,629 
age (years) 39.2 (4.3) 39.4 (4.4) 
follow-up (years) 11.8 (2.3) 12.0 (2.2) 
systolic blood pressure (mmHg) 132.8 (16.2) 126.7 (17.6) 
diastolic blood pressure (mmHg) 81.1 (11.2) 77.8 (11.0) 
body mass index (kg/m2) 24.9 (3.0) 24.3 (3.7) 
smokers (%) 65.6 47.0 
hypertensive (%)* 33.1 23.7 
treated hypertensive (%) 6.7 17.2 
hypertension: systolic blood pressure > 140 mmHg and/or diastolic blood pressure ä 90 
mmHg and/or use of antihypertensive medication 
associated with CHD, CVA, CVD and total mortality (Table 2). Also, isolated 
systolic hypertension was significantly associated with CVA and CVD mortality. 
In men 28% of CHD mortality, 58% of CVA mortality, 31% of CVD mortality 
and 18% of total mortality were attributable to elevated blood pressure. In 
women mild hypertension was related to CVA, CVD and total mortality (Table 
3). For severe hypertension increased relative risks were observed for all 
endpoints but these were only significant for CHD. Isolated systolic 
hypertension was only related to CHD mortality in women. In women the 
percent of cause-specific death attributable to elevated blood pressure ranged 
from 7% (total mortality) to 27% (CVA). 
After excluding persons with a history of angina pectoris (n=1205), 
myocardial infarction (n=26), stroke (n=116) and diabetes mellitus (n=420) at 
baseline the results remained virtually identical in men. The association between 
mild hypertension and CVA mortality became weaker in women but remained 
significant (RR of 3.8 versus RR of 2.6 (95% CI 1.09-6.16)). After excluding 
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CHD death rate/10,000 person-years 
<120 120-129 130-139 140-149 150-159 160-169 »170 
CVA death rate/10,000 person-years 
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<120 120-129 130-139 140-149 150-169 160-169 »170 
CVD death rate/10,000 person-years 
<120 120-129 130-139 140-149 150-159 160-169 »170 
SBP (mmHg) 
Figure 1. CHD, 
CVA, CVD and TM 
(total mortality) 
death rates per 
10,000 person-years 
by level of systolic 
blood pressure 
(SBP) for men and 
women aged 30-55 
years. Adjusted for 
age, serum 
cholesterol, body 
mass index and 
smoking. 
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CHD death rate/10,000 person-years 
<80 80-89 90-99 
CVA death rate/10,000 person-years 
«80 80-89 90-99 
CVD death rate/10,000 person-years 
<80 80-89 90-99 
TM death rate/10,000 person-years 
Figure 2. CHD, 
CVA, CVD and TM 
(total mortality) 
death rates per 
10,000 person-years 
by level of diastolic 
blood pressure 
(DBP) for men and 
women aged 30-55 
years. Adjusted for 
age, serum 
cholesterol, body 
mass index and 
smoking. 
80-89 90-
DBP (mmHg) 
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subjects who were on antihypertensive medication (n=1562) the results remained 
the same except that in women the association between blood pressure and CVA 
mortality became weaker. Adjustment for diabetes mellitus, history of angina 
pectoris, myocardial infarction, stroke and antihypertensive medications did not 
influence the results appreciably. 
The association between hypertension and CHD mortality did not differ 
between lean and obese men (Figure 3). There was some indication that the 
relative risk for CHD mortality was higher in lean hypertensive women than in 
obese hypertensive women. The relative risk for CVA mortality was higher in 
hypertensive obese men than in hypertensive lean men while the relative risk did 
not differ between lean and obese hypertensive women. The relative risk for 
CHD and CVA mortality was somewhat higher in hypertensive nonsmokers than 
smokers, particularly in women (Figure 4). For both hypertensive men and 
women the death rates were higher for smokers than for nonsmokers. 
DISCUSSION 
The results of the present study indicate that both elevated systolic and diastolic 
blood pressure were related to CHD, CVA, CVD and total mortality in men and 
women. In women the relative risks were not always significant due to the small 
number of cases. For total and cause-specific mortality the absolute rate, relative 
and attributable risks were higher in men than in women. Significant interactions 
with BMI and smoking were not observed. 
In the present study age varied between 30-54 years. However, most men 
and women were between 35 and 45 years old (n=32,631). Because of this 
rather homogeneous age distribution it is less meaningful to stratify the analyses 
by age. In the present study blood pressure values were based on a single 
measurement. Analysis based on one measurement is likely to lead to an 
underestimation of the true strength of the relationship between blood pressure 
and mortality risk. This implies that the true effects are stronger than those 
observed in the present study (2). It is estimated that the true association 
between diastolic blood pressure and stroke and CHD risk was about 60% 
stronger than the association based on a single reading or the average of two 
consecutive readings at one visit (2,24). 
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Table 2. Total, CHD, CVA and CVD mortality death rates (per 10,000 person-years) and 
relative risk(RR) estimates by classification of hypertension by blood pressure level for men. 
classification of 
hypertension' 
number #death Rate RR 2 95% CI PAR 
coronary heart disease 
normotension 15,664 82 4.42 1.00 0.28 
mild hypertension 4,007 57 11.99 2.18 1.54- 3.09 
severe hypertension 687 27 33.16 4.74 2.98 - 7.52 
isolated systolic 
hypertension 
2,816 28 8.23 1.52 0.98 - 2.34 
cerebrovascular disease 
normotension 15,735 11 0.59 1.00 0.58 
mild hypertension 4,049 15 3.16 5.66 2 .54- 12.63 
severe hypertension 711 3 3.69 6.42 1.73 - 23.87 
isolated systolic 
hypertension 
2,835 9 2.65 4.30 1.76- 10.48 
cardiovascular disease 
normotension 15,626 120 6.46 1.00 0.31 
mild hypertension 3,974 90 18.93 2.53 1.91 - 3.35 
severe hypertension 680 34 41.76 4.69 3.14- 7.01 
isolated systolic 
hypertension 
2,804 40 11.76 1.54 1.07 - 2.21 
total mortality 
normotension 15,320 441 23,74 1.00 0.18 
mild hypertension 3,865 201 42.26 1.70 1.43 - 2.02 
severe hypertension 639 75 92.12 3.47 2.69 - 4.47 
isolated systolic 
hypertension 
2,747 101 29.66 1.14 0.92- 1.42 
1 normotension: SBP <140 and DBP <90 mmHg, mild hypertension: SBP 140-180 and/or 
DBP 90-105 mmHg, severe hypertension: SBP >180 and/or DBP >105 mmHg, isolated 
systolic hypertension: SBP >140 and DBP <90 mmHg. 
2 adjusted for age, serum cholesterol, body mass index and smoking. 
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Table 3. Total, CHD, CVA and CVD mortality death rates (per 10,000 person-years) and 
relative risk(RR) estimates by classification of hypertension by blood pressure level for 
women. 
classification of 
hypertension1 
number #death Rate RR 2 95% CI PAR 
coronary heart disease 
normotension 19,883 19 0.80 1.00 
mild hypertension 2,898 8 2.26 1.59 0.65 - 3.89 0.19 
severe hypertension 503 3 4.91 3.15 0.87 - 11.42 
isolated systolic 
hypertension 
2,297 8 2.82 2.41 1.03 - 5.66 
cerebrovascular disease 
normotension 19,882 20 0.84 1.00 
mild hypertension 2,895 11 3.11 3.79 1.74 - 8.24 0.27 
severe hypertension 505 1 1.64 2.22 0.29 - 17.10 
isolated systolic 
hypertension 
2,302 3 1.06 1.27 0.37 -4 .35 
cardiovascular disease 
normotension 19,853 49 2.06 1.00 
mild hypertension 2,884 22 6.23 2.21 1.29 - 3.79 0.19 
severe hypertension 502 4 6.55 2.33 0.81 - 6.65 
isolated systolic 
hypertension 
2,292 13 4.58 1.76 0.94 - 3.31 
total mortality 
normotension 19,573 337 14.13 1.00 0.07 
mild hypertension 2,823 83 23.92 1.36 1.06 - 1.76 
severe hypertension 487 20 32.74 1.78 1.11 - 2.83 
isolated systolic 
hypertension 
2,245 61 21.50 1.24 0.93 - 1.64 
1 normotension: SBP <140 and DBP <90 mmHg, mild hypertension: SBP 140-180 and/or 
DBP 90-105 mmHg, severe hypertension: SBP >180 and/or DBP >105 mmHg, isolated 
systolic hypertension: SBP >140 and DBP <90 mmHg. 
2 adjusted for age, serum cholesterol, body mass index and smoking. 
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relative risk for CHD mortality 
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Figure 3. Number of cases and relative risk (RR) for CHD and CVA mortality by degree of 
obesity (BMI >25 kg/m2) for hypertensive men and women (between brackets 95% confidence 
interval). RR adjusted for age, serum cholesterol, body mass index and smoking. Hypertension 
defined as SPB >140 mmHg and/or DBP >90 mmHg and/or use of antihypertensive 
medication. 
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Figure 4. Number of cases and relative risk (RR) for CHD and CVA mortality by smoking 
status for hypertensive men and women (between brackets 95% confidence interval). RR 
adjusted for age, serum cholesterol and body mass index. Hypertension defined as SPB >140 
mmHg and/or DBP >90 mmHg and/or use of antihypertensive medication. 
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From a recent review of US population data, it was concluded that 
systolic and diastolic blood pressure have a continuous and graded relationship 
with mortality from CHD, CVA and CVD in both men and women (5). Also in 
the Copenhagen Heart Study the risk for CHD and CVA mortaUty increased 
with increasing quintiles of systolic and diastolic blood pressure in both men and 
women (9). The Bergen Study from Norway showed exponentional relations. 
The findings of the present study and those from other studies suggest that the 
relation between blood pressure and mortality is linear in both sexes. 
In the present study both the absolute rate and relative risks were higher 
in men than in women. Also in other studies the absolute rates were higher in 
men than in women but in most of these studies the relative risks were about the 
same for men and women (5,8,9,25). Based on the evidence available it can be 
concluded that the strength of the association between blood pressure and 
mortality is similar in men and women. 
Isolated systolic hypertension has been mainly evaluated in the elderly 
(26). However, a few studies have investigated the association been isolated 
systolic hypertension in subjects less than 60 years (27,28). In the MRFTT study 
isolated systolic blood pressure was related to CHD, CVA and total mortality. 
Van den Ban et al. observed a relation between isolated systolic blood pressure 
and total mortality in both men and women. Because of the differences in 
definitions of isolated systolic hypertension the absolute and relative risks in 
different studies can not be compared. However, the present study confirms the 
association between isolated systolic hypertension and CHD, CVA and total 
mortality for middle aged men and shows for the first time that isolated 
hypertension is associated with CHD mortaUty in women. 
The present study indicates that the relative risk for CHD and CVA 
mortality did not differ between lean and obese hypertensive men and women. 
However, there was an indication that the association between hypertension and 
CHD mortality was slightiy stronger in lean women than in obese women. 
Because of the small number of cases the importance of the interaction with 
obesity is unclear. Some studies observed an excess mortality risk in lean 
hypertensive men and women (10-13) but others did not (14-16,29). This can 
partly be due to the fact that the definition of 'lean and obese' and 
'hypertension' varies between the different studies and to different age groups 
studied. 
In the MPvFIT study and the British Regional Heart Survey it was 
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observed that the risk of CHD mortality was higher in hypertensive smokers 
than in hypertensive nonsmokers (17,18). However, in the present study there 
was a tendency that the association was stronger in hypertensive nonsmokers 
than in hypertensive smokers. The confidence intervals for hypertensive smokers 
and hypertensive nonsmokers were overlapping and rather wide. Also no 
plausible mechanism is known why the relationship will be stronger in 
hypertensive nonsmokers than in hypertensive smokers. Therefore, no conclusion 
can be drawn whether smoking is an effect modifier or not. 
From a public health point of view it is important to know what the effect 
will be of blood pressure reduction. The potential effect of a diastolic blood 
pressure reduction of 6 mmHg on CHD and CVA mortality based on a meta-
analysis of a large number of prospective studies was for CHD 20-25% and for 
CVA 35-40% (Table 4) (2,30). Similar results were observed for men in the 
present study. For women, however, no results from other studies were 
available. The reduction in CHD mortality was not significant while a significant 
reduction was observed for CVA, CVD and total mortality. However, the public 
health impact of blood pressure seems to be lower in women compared with 
men except for CVA mortality. 
Table 4. CHD, CVA, CVD and total mortality reduction as a result of a 6 mmHg reduction 
in diastolic blood pressure in the present study and the meta-analysis of Collins et al. and 
MacMahon et al.(2,30). 
Cause of death Collins/MacMahon Present study 
men and women1 men women 
coronary heart disease 20-25% 39% (28-50%) 7% (0-36%) 
cerebrovascular disease 35-40% 49% (26-72%) 46% (20-72%) 
cardiovascular disease 4 1 % (32-50%) 29% (11-47%) 
total mortality 28% (22-34%) 12% (4-20%) 
1 96% of the population was men. 
The results of the present study suggests that systolic blood pressure above 140 
mmHg and diastolic blood pressure above 90 mmHg is associated with CHD, 
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CVA, CVD and total mortality. In men reduction in blood pressure results in a 
larger reduction in mortality risk than in women. Because the prevalence of 
hypertension is higher in men than in women and middle aged men are more 
likely to develop CVD than women, more attention should be paid to treatment 
of hypertension in men. This is in contrast to current medical practice in the 
Netherlands in which treatment of hypertension is more common in women than 
in men. 
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GENERAL DISCUSSION 
High blood pressure is associated with cardiovascular morbidity and mortality, 
as well as total mortality, is a major public health problem. From a public health 
perspective it is firstly, of interest to monitor blood pressure levels and to find 
out what percentage of mortality from coronary heart disease, cerebrovascular 
disease, cardiovascular diseases and all causes can be attributed to elevated 
blood pressure. Secondly, it is interesting to find out what the potential effect 
of lowering blood pressure on cause-specific and total mortality could be in the 
population. For primary prevention of hypertension and non-pharmacological 
treatment, it is important to determine the modifiable factors which influence 
systolic and diastolic blood pressure. These questions have been studied in the 
research behind this thesis. The results described are based on data from the 
following three projects: the Consultation Bureau Heart Project (CB Heart 
Project), the Coronary Heart Disease Risk Factor Project (PJFOH Project) and 
the Cardiovascular Risk Factors Monitoring Project (CRFM Project). The 
investigations presented deal with: 
1 trends in blood pressure 
2 lifestyle factors and blood pressure 
3 blood pressure as a determinant of cause-specific and total mortality. 
Trends in blood pressure 
Between 1974 and 1986 two screening projects on cardiovascular risk factors 
were carried out in the Netherlands (Table 1). The first screening project 
'Consultation Bureau Heart Project' (CB Heart Project) was carried out between 
1974 and 1980. In this period about 30,000 men and women aged 37-43 years 
were examined. The second screening project the 'Coronary Heart Disease Risk 
Factor Project' (RTFOH Project) was carried out between 1980-1986. In this 
period about 80,000 men aged 33-37 years were examined. The aim of these 
two projects was to identify high-risk persons and to advise them on changes in 
lifestyle or if necessary start treatment. Between 1987 and 1991 the 'Monitoring 
Project on Cardiovascular Risk Factors' (CRFM Project) was carried out. The 
aim of this project was to study levels and trends in major risk factors for 
cardiovascular diseases. In this period about 36,000 men and women aged 20-59 
years were examined. An advantage of these three studies was that blood 
pressure was measured continuously using standardized methodology. The trends 
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in these three projects are based on average monthly blood pressure 
measurements. Between 1974 and 1980 an increase in systolic blood pressure 
of 2 mmHg in men was followed by an insignificant change during the period 
1981-1986. Average diastolic blood pressure increased by 4 mmHg between 
1974 and 1980, but decreased by the same amount between 1981-1986. Average 
systolic blood pressure did not change in women aged 37-43 years between 
1974-1980, but average diastolic blood pressure increased by 2 mmHg during 
that period. Between 1987 and 1991, systolic blood pressure decreased by 2 
mmHg and diastolic blood pressure increased by 1 mmHg in both men and 
women. 
Table 1. Main trends in systolic and diastolic blood pressure (SBP, DBP), and prevalence and 
treatment of hypertension in men and women 
Project Survey Age SBP DBP Hypertension1 Treatment2 
year (years) (mmHg) (mmHg) (% change) (% change) 
Men 
CB 1974-1980 37-43 + 2 + 4 + 5 + 13 
R1FOH 1981-1986 33-37 0 - 4 0 + 4 
CRFM 1987-1991 20-59 - 2 + 1 0 - 10 
Women 
CB 1974-1980 37-43 0 + 2 0 0 
CRFM 1987-1991 20-59 - 2 + 1 0 -11 
1 Hypertension= SBP ^160 mmHg and/or DBP >95 mmHg and/or use of antihypertensive 
medication. 
2 Treatment=proportion of hypertensive subjects who were treated for hypertension. 
In all three studies several measures were taken to standardize the blood 
pressure measurements. A random zero sphygmomanometer was used to reduce 
observer bias in blood pressure measurement. The random zero sphygmomano-
meters were regularly calibrated. The same technicians did the blood pressure 
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measurements in the different study periods. They received detailed instructions 
on how to use the random zero sphygmomanometer (1). They were all in-
structed by the same physician in same study period. In the CB Heart Project 
blood pressure was measured after an electrocardiogram was made. The subjects 
had rested for about 10 minutes. In the RIFOH and CRFM Projects no electro-
cardiogram was made. In these two projects blood pressure was measured after 
the technician had checked the questionnaire with the participants. Thus blood 
pressure was also measured after 5 to 10 minutes rest. 
In the CB Heart Project and the RIFOH Project one cuff-size was 
available, while in the CRFM project three cuff-sizes were used. In the CRFM 
Project a larger cuff was used for about 1.1% of the subjects and a smaller cuff 
was used for about 0.4% of the subjects (Chapter 3). The percentage of subjects 
in which a larger cuff was used was low because adults in the Netherlands are 
rather thin compared to their counterparts in the USA and Canada (2). In all the 
three projects the average BMI was 25 kg/m2. When using too small a cuff 
technicians can overestimate blood pressure (3). Based on the experience in the 
CRFM project, it can be assumed that also in the CB Heart and RIFOH Projects 
probably a small percentage of subjects required a larger or smaller cuff. 
Differences in average blood pressure between the study periods cannot be 
explained by using an inappropriate cuff size because of the small number of 
persons for which a cuff size other than the standard was used. 
In the CB Heart and RIFOH Projects blood pressure was measured once, 
while in the CRFM Project it was measured twice. To compare the average 
blood pressure levels from the three studies with each other, the first blood 
pressure measurement was taken from the CRFM project. When the CRFM 
Project age ranges comparable with the age ranges in the CB Heart and RIFOH 
Project were taken, it appeared that blood pressure in the CRFM Project was 
lower than in the other two projects (Tables 2 and 3). The average blood 
pressure in the RIFOH project was also lower than in the CB Heart Project. 
With each study the standard deviations also became smaller. 
In spite of the standardization of the blood pressure measurement, we 
observed considerable differences between the average blood pressure levels 
during different study periods. Within a study period changes in blood pressure 
were minor. To gain insight into whether this phenomenon was specific for this 
project or universal, trend studies carried out in other countries were considered. 
Included are study in Japan, with almost yearly measurements over a long 
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Table 2. Mean systolic and diastolic blood pressure1 (mmHg) in men in 1976 and 1979 (CB 
Project)2, 1981, 1986 (RIFOH Project), and 1987 and 1991 (CRFM project) 
Project Year Age Number SBP (SD) DBP (SD) 
CB Heart 1976 37-43 2195 132.2 (16.7) 80.3 (11.0) 
CB Heart 1979 37-43 2204 133.4 (16.6) 83.7 (11.6) 
RIFOH 1981 33-37 5068 128.1 (14.4) 81.0 (10.4) 
RIFOH 1986 33-37 7149 128.9 (14.4) 77.1 (10.3) 
CRFM 3 1987 33-37 275 123.3 (12.3) 76.0 (9.7) 
CRFM 1991 33-37 346 121.2 (12.6) 76.8 (9.5) 
1 Average based on data from Amsterdam, Doetinchem and Maastricht. 
2 Data from Amsterdam, Doetinchem and Maastricht were only available for the years 1976, 
1977, 1978 and 1979. 
3 Only the first blood pressure measurement is used. 
Table 3. Mean systolic and diastolic blood pressure1 (mmHg) in women in 1976 and 1979 
(CB Heart Project)2, and 1987 and 1991 (CRFM project) 
Project Year Age Number SBP (SD) DBP (SD) 
CB Heart 1976 37-43 2290 126.8 (16.9) 77.0 (10.9) 
CB Heart 1979 37-43 1551 126.2 (16.7) 78.7 (11.2) 
CRFM 3 1987 37-43 562 115.3 (13.6) 73.6 (9.8) 
CRFM 1991 37-43 669 114.2 (14.1) 74.1 (10.3) 
1 Average based on data of Amsterdam, Doetinchem and Maastricht. 
2 Data from Amsterdam, Doetinchem and Maastricht were only available for the years 1976, 
1977, 1978 and 1979. 
3 Only the first blood pressure measurement is used. 
period of time (4,5), and some studies in Finland and the USA with only a few 
measurements over long periods (Table 4, Figures 1 and 2) (6,7). These studies 
were selected because several measurements were done during a long time 
period and the studies were conducted in about the same time frame as 
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Table 4. Mean systolic and diastolic blood pressure (SBP, DBP, mmHg) in different countries 
Country/area Men Women 
(references) Year Age Number Mean SBP Mean DBP Number Mean SBP Mean DBP 
Finland/Kuopio Province (6)1 
Japan (4,5) 
USA, Minnesota (7) 3 
1972 30-59 2520 146.0 93.3 2621 147.2 91.3 
1977 2607 145.7 92.6 2747 142.9 88.4 
1982 1207 146.5 88.9 999 143.3 84.8 
1987 599 144.4 89.1 631 138.9 83.9 
1992 582 140.1 83.8 624 135.5 79.8 
1975 40-49 137.0 85.0 133.0 80.0 
1980 135.0 84.0 130.0 80.0 
1985 132.5 83.0 129.0 79.0 
1990 131.0 83.0 126.5 78.0 
1973 25-59 1724 122.8 77.4 1890 115.6 71.9 
1980/82 1375 122.2 75.6 1533 115.1 71.0 
1985/87 1881 121.6 74.8 2006 113.6 70.4 
1 In 1972/77 shorter cuff was used than in 1982/87. Shorter cuff reading 4 mmHg higher than with larger cuff. 2 Numbers for the age category 
40-49 years were not available. 3 In 1973 mercury spygmomanometer and later random zero spygmomanometer used. Mean blood pressure 
adjusted for difference in method. 
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Figure 1. Trends in systolic and diastolic blood pressure in men in different countries. 
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Figure 2. Trends in systolic and diastolic blood pressure in women in different countries. 
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ours. Our results cover a long period but come from three different projects. 
Generally, all studies showed a decreasing trend in time. The Japanese study 
confirms the fact that conclusions on trends in blood pressure should be made 
with caution and based on measurements which are five years apart. Continuous 
well-controlled series of measurements are needed to obtain reliable information 
about trends. Conclusions based on measurements taken with 5 to 10 year 
intervals like in Finland and the USA may not be justifiable (6,7). 
A possible reason for the difference in average blood pressure and the 
standard deviation between different study periods is that patient-related factors 
may result in errors which are, for instance, larger than those made by the use 
of an inappropriate cuff-size (8). The anxiety caused by the physician measuring 
the blood pressure may in itself produce a substantial increase which is often 
referred to as white-coat effect (8,9). The CB Heart and RIFOH Projects were 
both screening projects aimed at identifying high-risk persons, which means that 
when increased risk factors or electrocardiographic changes were observed, 
advice on hygiene and/or treatment could be started. The differences in average 
blood pressure could result from the type of project, i.e.a. screening versus a 
monitoring project. In a screening project the white-coat effect is probably larger 
than in a monitoring project. 
We observed differences in average blood pressure measurements among 
the 15 technicians in the CRFM Project. The systolic blood pressure averages 
varied between 114.5 and 124.1 mmHg, with a mean of 120.2 mmHg and a 
standard deviation of 2.5 mmHg. The diastolic blood pressure averages varied 
between 72.6 and 81.1 mmHg, with a mean of 76.6 mmHg and a standard 
deviation of 2.3 mmHg. The observed variation in blood pressure averages 
among different technicians is not surprising for a method that depends on the 
ability to detect sounds produced in the artery. It was not possible to 
differentiate between the technicians from the other two projects. It seems 
unlikely that differences in blood pressure measurements among the technicians 
in the other projects was very different. Therefore the differences in average 
blood pressure seen between the projects probably cannot be explained by the 
differences in blood pressure measured by different technicians. 
Prevalence and treatment of hypertension 
Between 1974 and 1980 an increase in the prevalence of hypertension was 
observed in men but not in women (Table 1). Between 1981 and 1986 the 
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prevalence of hypertension remained stable in men. Between 1987 and 1991 the 
prevalence of hypertension remained stable in both men and women. An 
increase in the percentage of treated hypertensive men between 1974 and 1986 
was followed by a decrease in the period 1987 and 1991. When a decrease in 
the treatment of hypertension was in women also seen. 
As far as we know, no other studies are available in which trends in 
hypertension using the same definition as in our study were evaluated. We 
compared the prevalence of hypertension observed in the CRFM Project with 
the prevalence of hypertension in the MONICA Study (10). Thirty-nine 
collaborative centres in 26 countries participated in the MONICA Study. They 
used almost the same method for the blood pressure measurement as in our 
study except that in 29 centres the mercury sphygmomanometer was used in-
stead of the random zero sphygmomanometer. Blood pressure was measured in 
the right arm instead of the left. In the MONICA Study the same definition for 
hypertension was used as the one we used. The age range in the MONICA 
Study was 35-64 years (estimated average standardized age of about 46 years) 
versus 20-59 years (average standardized age of 38 years) in the CRFM Project. 
In the CRFM Project the prevalence of hypertension increased with age at about 
1% per year in both men and women aged 40-59 years. This age range was 
taken because the relation between age and hypertension was not linear until 
after the age of 40 when the increase was more or less linear (11). The 
prevalence in our study was 8% (weighted for age distribution and corrected for 
the technician who measured the blood pressure) (Chapter 3). Between 38 and 
46 years hypertension increases by about 8%. When we adjust for the age 
difference, the estimated prevalence of hypertension at the age of about 46 
would be about 16%. We have to be very careful when comparing our results 
with those of the MONICA Study because we used an estimate of the average 
age and prevalence of hypertension. 
The Netherlands seems to have a low to intermediate position compared 
to other West European countries participating in the MONICA Study. In the 
INTERS ALT Study 200 men and women aged 20-59 from 52 populations and 
32 countries were examined. The method of blood pressure measurement in this 
study was standardized very well. The prevalence of hypertension was difficult 
to estimate because of the relatively small number of persons examined. Taking 
these limitations into account, the Netherlands in comparison with other 
countries was shown to have an intermediate position (12). 
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In the CB Project more women were treated for hypertension than men. 
Between 1974 and 1980 the percentage of treated hypertensive women remained 
stable, while during 1974 and 1986 the percentage of treated hypertensive men 
increased. In the CRFM Project it was observed that pharmacological treatment 
in both hypertensive men and women decreased between 1987 and 1991. In 
hypertensive women, also non-pharmacological treatment or a combination of 
non-pharmacological and pharmacological treatment decreased. In hypertensive 
men, non-pharmacological treatment remained stable, while the combination of 
non-pharmacological and pharmacological treatment decreased. This means that 
a decrease in hypertensive treatment with medication was not replaced with an 
increase in non-pharmacological treatment, while the prevalence of hypertension 
in both men and women did not change during that period. The decrease in 
pharmacological treatment can be due to the debate in the mid-eighties among 
general practitioners in the Netherlands about the usefulness of pharmacological 
treatment for mild hypertension (13). The Dutch guidelines for hypertension 
advise general practitioners to pay more attention to non-pharmacological 
treatment, and that the start of pharmacological treatment should also depend on 
the presence of other risk factors (14). Physicians increasingly based the 
diagnosis of hypertension on multiple blood pressure measurements rather than 
a single measurement. This resulted in a smaller number of subjects treated for 
hypertension because only the 'real' hypertensives were treated. The prevalence 
of hypertension in persons above ages 40-59 amounted to 15% in men and 13% 
in women in 1987 and remained stable in the period 1987-1991. In view of this 
sustained high prevalence more attention will need to be paid to primary and 
secondary prevention of high blood pressure through health education 
programmes in weight control, alcohol and salt restriction and increasing 
potassium intake. 
Lifestyle factors and blood pressure 
Overweight, high sodium and alcohol intake are presendy considered the most 
important determinants of high blood pressure (15,16). Potentially protective 
effects have been suggested for high intakes of potassium, magnesium and 
calcium. The effect of physical activity on blood pressure is less clear (17). In 
this thesis only the associations between blood pressure and alcohol 
consumption, potassium, magnesium and calcium intake have been investigated. 
The relation between sodium intake and blood pressure has not been studied 
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because in the present study no information was available about the amount of 
salt added during preparation of the meals and at the table. The relation between 
weight, body mass index, physical activity and blood pressure in the population 
studied is currently or will be investigated in the near future. The relation 
between blood pressure and alcohol consumption was studied because the nature 
of the relation is still unclear and little is known about effect modification of the 
relation between alcohol and blood pressure by other determinants such as 
smoking. The relations between dietary minerals and blood pressure were 
studied because little is known about the combined effect of dietary potassium, 
magnesium and calcium on blood pressure. The results from this thesis will be 
compared with those from other observational and experimental studies, and 
possible mechanisms on how lifestyle factors may influence blood pressure will 
be discussed. Conclusions will be drawn about the importance of lifestyle factors 
in prevention and treatment of hypertension. 
Alcohol 
In most cross-sectional studies a positive relationship between blood pressure 
and alcohol consumption has been observed (15, 18). This relationship persisted 
even after adjustment for body mass index, cigarette smoking, age, total serum 
cholesterol and heart rate. Both linear and non-linear relationships have been 
reported. U- or J-shaped relationships, or a threshold level, have been observed. 
Most studies have indicated elevated blood pressure levels in persons drinking 
three or more glasses per day in comparison with non-drinkers. In the CRFM 
project we observed a linear relationship for men and a threshold at two glasses 
per day for women. The U- or J-shaped relationship observed in other studies 
can be due to the fact that the category non-drinkers includes subjects who may 
have stopped drinking because of health problems or subjects using 
antihypertensive medication or a prescribed diet (19). 
Prospective studies also provide consistent evidence of a strong 
relationship between baseline alcohol intake and the incidence of hypertension 
(15,20,21). A change in alcohol intake has also been associated with a change 
in blood pressure. In a randomized controlled trial in normotensive males a 
reduction in alcohol intake of 70 ml/week resulted in a reduction of about 3 
mmHg in systolic blood pressure (18,20). The reduction in diastolic blood 
pressure was smaller and not statistically significant. In another randomized 
controlled trial a weekly alcohol reduction from 452 to 64 ml was associated 
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with a fall in systolic and diastolic blood pressure of 5 and 3 mmHg, 
respectively, in three weeks in hypertensive men (17). The results of the trials 
and observational studies suggest that a reduction in alcohol intake is effective 
in lowering blood pressure in both hypertensive and normotensive individuals 
and may help to prevent hypertension. Still, there is no agreement about the 
acceptable level of alcohol consumption in relation to blood pressure. In most 
studies blood pressure was elevated in persons consuming three or more glasses 
per day in comparison with non-drinkers. Based on our results and those from 
other studies it is not possible to make a statement about acceptable alcohol 
consumption levels in relation to blood pressure. 
The effect of alcohol on blood pressure can be explained by its influence 
on both the cardiac output and/or the peripheral vascular resistance, as these two 
haemodynamic characteristics determine the arterial blood pressure (18). This 
influence may be due to: an increase in sympathetic nervous system activity, as 
indicated by elevated concentrations of circulating catecholamines; activation of 
the renin angiotensin system; an increase in circulating vasopressin and 
aldosterone; elevation of plasma Cortisol level; a rise in cardiac output and the 
cardiac index, or enlargement of the circulating volume due to water and salt 
retention (17,18). 
Minerals 
Potassium 
In the CFRM Project an inverse association between potassium intake and blood 
pressure was observed in both men and women. Both epidemiologic studies and 
clinical trials have suggested that an increase in potassium intake lowers blood 
pressure (22). However, some clinical trials have clearly shown the beneficial 
effect of oral potassium supplements on blood pressure; other studies have failed 
to confirm this. There may be a number of possible explanations for the 
discrepancy between the studies. This can be due partly to insufficient sample 
size, heterogeneity of blood pressure response and absence of placebo-controlled 
studies. Therefore, a meta-analysis was carried out (22). The results of this 
meta-analysis indicate that an average potassium supplement of 86 mmol per 
day produced a significant reduction on supine systolic and diastolic blood 
pressure of 5.9 and 3.4 mmHg, respectively, in normotensive subjects and an 
even greater reduction in systolic and diastolic blood pressure of 8.2 and 4.5 
mmHg, respectively, in hypertensive subjects. The effect of oral potassium on 
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standing blood pressure was greater than for supine blood pressure. Based on the 
results of these studies, an increase in potassium intake should be included in 
the recommendations for a non-pharmacological treatment of hypertension. 
Various mechanisms have been proposed to explain the possible effect of 
potassium on blood pressure (15). These include a direct natriuretic effect, 
suppression of the renin-angiotensin and sympathetic nervous systems, 
improvement of the baroreceptor function, and the reduction of peripheral 
vascular resistance by direct arterial vasodilation. 
Magnesium 
In our study and most other observational studies an inverse association between 
magnesium intake and blood pressure was observed (15). In the uncontrolled 
trials a significant fall in systolic and diastolic blood pressure was noticed (23). 
However, in most of the double-blind placebo controlled trials on magnesium 
supplementation and blood pressure, no significant fall in blood pressure was 
observed (23,24). It is possible that the placebo-controlled trials did not have 
enough power to detect an effect on blood pressure. These trials were also of 
short duration. In one double-blind randomized trial of six months the effect of 
magnesium supplementation on blood pressure was studied among 91 women 
with mild to moderate hypertension (25). Only in diastolic blood pressure was 
a significant fall observed. In the Trial Of Hypertension Prevention (TOHP) a 
group of 227 patients with diastolic blood pressure between 80 and 89 mmHg 
was randomized to a period of magnesium supplementation and their blood 
pressure response was compared to a group of 234 patients given placebo for 
six months (26). No blood pressure-lowering effect due to magnesium 
supplementation was detected. The available data provide insufficient evidence 
to recommend magnesium supplementation for the prevention of hypertension. 
Magnesium is a regulator of the parathyroid hormone, which has a direct 
effect on blood pressure (23). Magnesium is known to be important co-factor for 
activation of the Na+-K+-ATPase activity, which plays an important role in the 
regulation of the vascular tone and reactivity. Magnesium is also a laxans which 
also increases the excretion of sodium. 
Calcium 
In the CRPM Project calcium intake was inversely related to diastolic blood 
pressure in men, and to systolic and diastolic blood pressure in women. Blood 
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pressure hardly differed between users of calcium supplements and non-users. 
The majority of the observational studies provides evidence for an inverse 
relationship between calcium intake and blood pressure (15). This relationship 
could have been influenced by confounding variables, especially sodium, which 
was either measured not or not well in these studies. Over the past few years, 
several trials on the effect of oral calcium supplementation on blood pressure 
have been undertaken, both in normotensive and hypertensive subjects (15). The 
results of these trials are inconsistent and the effect of calcium supplementation 
on blood pressure remains a subject of controversy (27). Therefore a meta-
analysis was carried out. Results of this meta-analysis indicate that the overall 
effect of calcium supplementation on blood pressure, if any, is very small and 
confined to standing blood pressure. Based on the evidence available it seemed 
prudent to consider the role of calcium in prevention and treatment of 
hypertension as unproven. 
Calcium intake could theoretically lead to changes in blood pressure by 
inducing changes in the parathyroid hormone, which has a direct effect on blood 
pressure (28). Calcium also plays a role in the regulation of the vascular tone 
and increased calcium intake has also a natriuretic effect (29). 
The combined effect of dietary potassium, magnesium and calcium 
Dietary potassium, magnesium and calcium are highly intercorrelated. Therefore, 
it was not possible to enter the three minerals at the simultaneously in a 
regression model in order to estimate the independent association between blood 
pressure and potassium, magnesium and calcium. The combined effect of the 
three minerals on blood pressure was investigated as an alternative. As far as we 
know there are no other studies in which the combined effect of potassium, 
magnesium and calcium were studied. We observed that men and women 
consuming a diet high in calcium, potassium and magnesium had 2 mmHg 
lower systolic and diastolic blood pressure levels than men and women 
consuming a diet low in these minerals (Chapter 5). These results were based 
on a study in which the food intake was measured through a food frequency 
questionnaire. Food intake estimated by a food frequency method results in an 
underestimation of the true association. The results of our study suggest that an 
increase in mineral intake can be an important contributing factor for a reduction 
in blood pressure of at least 2 mmHg. A reduction of 2 mmHg in diastolic blood 
pressure can result in a reduction in cardiovascular diseases of about 14% in 
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men and about 10% in women (Chapter 6). 
Sodium 
Excess sodium intake has been associated with increased systolic and diastolic 
blood pressure in both men and women. The evidence for this association is 
provided by both observational and experimental studies (15). From a meta-
analysis it appeared that a reduction in sodium chloride consumption of 3-6 
grams per day can result in an average reduction in systolic and diastolic blood 
pressure in hypertensive subjects of approximately 5 and 3 mmHg, respectively, 
and in normotensive subjects of 2 and 1 mmHg, respectively (30). This suggests 
that a reduction in salt intake can be an important contributing factor to a 
reduction in blood pressure. 
The mechanism whereby sodium affects blood pressure reflects its place 
in the sodium-renin-aldosterone-angiotensin control system that maintains blood 
pressure and flow through the balance of volume and vasoconstriction (17). 
Other lifestyle factors 
Body weight 
Both cross-sectional and prospective studies have shown a positive relation 
between body weight, body mass index and blood pressure (15). This 
relationship has been observed in both men and women. From the Intersalt 
Study the association between blood pressure and body mass index appeared 
somewhat stronger in men than in women (31). Two meta-analyses were 
conducted in which the effect of weight reduction on blood pressure was 
analyzed (32,33). It was calculated from 4 and 5 well-controlled studies that a 
weight reduction of 1 kg in obese hypertensive men and women resulted in a 
respective reduction in systolic blood pressure between 1.2 and 1.6 mmHg and 
in diastolic blood pressure between 1.0 and 1.3 mmHg. Subjects with a higher 
waist-to-hip ratio are even more likely to have a raised blood pressure and also 
have a greater risk of cardiovascular mortality (17). In general, men have higher 
waist-to-hip ratios than women. This can result in higher blood pressure levels 
in men than in women. 
Obesity may increase blood pressure by its effects on the sympathetic 
nervous system, activation of the plasma renin/aldosterone system, expansion of 
plasma volume and insulin resistance accompanied by hyperinsulinaemia (17). 
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Physical activity 
Most observational studies have suggested that individuals who have a more 
physically active lifestyle have lower blood pressure than less physically active 
individuals (17,34). In a recent review the results of 22 trials in which the effect 
of physical activity on blood pressure was studied were evaluated (35). Of the 
22 trials, including a control group, only 13 analyzed habitual physical activity. 
Of these studies only 1 did not have a major design fault. In this particular study 
30 men aged 39 years exercised one hour three times a week for a period of 16 
weeks. The type of exercise was cycling, callisthenics and jogging with an 
intensity of 75% V0 2 . A fall in both systolic and diastolic blood pressure of 5 
and 4 mmHg, respectively, was observed. However, a reduction in weight of 
about 2 kg was also observed. Taking the weight reduction into account, the 
reduction through physical activity can be estimated to be in the order of about 
1 to 2 mmHg. In spite of all the design problems in the other studies (such as 
failure to randomize, absence of a blind blood pressure measurement, the use of 
a before-and-after design, no detailed information on the intensity, weight 
change not reported) there was a consistent finding that physical activity lowered 
blood pressure in both normotensive and hypertensive persons. Most of the 
studies included only men. When both sexes were included women were in the 
minority. The frequency of the exercise was, in most studies, at least three times 
a week. In most studies the intensity was between 60-70% V0 2 . The frequency 
and the intensity in most of these studies is high, so that for practical purposes 
such an intensive physical activity programme cannot be used in the prevention 
and treatment of hypertension. 
In a recent randomized trial of adequate power in 99 non-obese men and 
women with mild hypertension, no reduction in blood pressure was observed 
after the subjects had spent 30-60 minutes in supervised jogging or walking at 
70% of maximum initial oxygen consumption during three sessions per week 
(36). The body weight remained constant during this period. The available data 
provide some evidence for recommending physical activity in non-
pharmacological treatment and in the prevention of hypertension. Although, the 
effect on blood pressure is not known, it can reduce body weight, which then 
results in a decrease in blood pressure. 
The mechanism for an exercise-induced reduction of blood pressure is 
uncertain, but it is possible that decreased sympathetic nerve activity plays a role 
(17). Physical activity may increase cardiac output and decrease peripheral 
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vascular resistance (35). 
Cigarette smoking 
Smoking does not seem to be a determinant of blood pressure (16). However, 
in the CRFM Project it was an important effect modifier of the alcohol-blood 
pressure relation in both men and women (Chapter 4). The relation between 
alcohol and blood pressure was stronger in male and female smokers than in 
male and female non-smokers. Only in a few studies was this interaction 
investigated (21,37,38). Arkwright and co-workers observed that diastolic blood 
pressure was lower in male smokers than in non-smokers even after adjustment 
for age and body mass index (38). In the Nurses Health Study no interaction 
was observed with smoking (37). However, in the MONICA Augsburg Studies 
an interaction with smoking was observed in both men and women (21). A 
possible explanation for the interaction with smoking may be that smoking is 
associated with a change in pattern of body fat distribution, which results in a 
higher waist-to-hip circumference ratio in smokers compared with nonsmokers 
(39). A higher waist-to-hip circumference ratio is correlated with 
hyperinsulinemia and hypertension (40). It is possible that smoking influences 
blood pressure by changing the body fat distribution (41). Based on the available 
data and a plausible mechanism we concluded that the prevalence of 
hypertension may be positively influenced by intervention in both alcohol and 
tobacco consumption. 
Combination of lifestyle factors 
A 5-year trial involving 201 men and women with high normal blood pressure 
at baseline (with a second-screen diastolic value of 85 to 89 mmHg) 
demonstrated the ability to reduce the incidence of hypertension in participants 
randomized to nutritional-hygienic intervention compared with a control group 
(42). Mean trial blood pressure was lower in the intervention group compared 
with the control group (-2.0 mmHg for systolic blood pressure and -1.9 mmHg 
for diastolic blood pressure). During the trial in the intervention group weight 
loss amounted to 2.2 kg, alcohol intake decreased by 10 g and salt intake by 2.3 
g. The majority of the participants in the intervention group reported an increase 
in physical activity. Effect on blood pressure was strongly related to degree of 
weight loss. 
In the Trial Of Hypertension Prevention (TOHP) three lifestyle groups 
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(weight reduction, sodium reduction and stress management) were each 
compared with non-intervention controls over 18 months (26). In addition, four 
nutritional supplement groups (calcium, magnesium, potassium and fish oil) 
were each compared singly, in a double-blind fashion, with placebo controls 
over six months. They concluded weight reduction to be the most effective 
strategy tested for reducing blood pressure in normotensive persons. However, 
a reduced body weight is notoriously difficult to sustain. Sodium reduction is 
also effective but less effective than weight reduction. 
Based on the results of our study and those of others it can be concluded 
that a reduction in body weight, and in alcohol and sodium intake, and an 
increase in potassium intake can result in a considerable reduction in blood 
pressure. When simply adding up the effects of these four modifiable factors a 
reduction of about 5-6 mmHg can be expected in hypertensive subjects. A 
reduction in diastolic blood pressure of 2 mmHg can be realized by an increase 
in potassium of about 2.5 grams per day, a decrease in salt intake of 2-4 grams 
per day or a reduction in body weight of about 2 kg. Furthermore, a reduction 
in alcohol consumption of one glass per day results in a diastolic blood pressure 
reduction of about 0.5 mmHg. The reduction in diastolic blood pressure due to 
the combined effect of these minor changes in lifestyle factors is in the same 
order of blood pressure reduction as can be obtained by pharmacological 
treatment (43). 
Stamler et al. observed a reduction in blood pressure of as little as 2 
mmHg through combined lifestyle interventions (42). The effect of these 
interventions on blood pressure were lower than could be expected on the basis 
of changes in salt intake, alcohol intake and body weight. This means that 
changes in blood pressure resulting from each of the separate determinants are 
not independent. Generally, the reduction in blood pressure is greater in 
hypertensive subjects than in normotensive subjects. This means that the effects 
of these measures cannot be added up or the observed small reduction in blood 
pressure observed by Stamler et al. is due to the fact that the intervention was 
done in subjects with a high normal blood pressure and not in real hypertensives 
(42). If all known preventive measures are applied in hypertensive subjects, it 
is theoretically possible to reduce diastolic blood pressure by 5-6 mmHg. 
A reduction in diastolic blood pressure of about 6 mmHg can result in a 
mortality reduction of about 41% for cardiovascular diseases and 28% for all 
causes in men, and 29% and 12% in women, respectively (Chapter 6). This 
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shows the large potential for a combined nutritional intervention, in hypertensive 
subjects at least. 
Mortality and blood pressure 
In this thesis and in most observational studies that both systolic and diastolic 
blood pressure are found to be strongly related to mortality from coronary heart 
disease, cerebrovascular disease, cardiovascular diseases and all causes (44,45). 
The mortality risk increases progressively throughout the entire blood pressure 
range. The type and strength of the association is about the same in men and 
women. However, the absolute mortality rate is higher in men than in women. 
Blood pressure also seems to be an important and independent risk factor in 
renal insufficiency and consequence (45). However, because of insufficient cases 
of renal diseases in the CB Project this association could not be studied. 
Cerebrovascular accident can be divided in cerebral infarction and hemorrhagic 
stroke. Cerebral infarction is the most common form of cerebrovascular accident 
in the Netherlands (about 80% of the cases) (46). Because of the small number 
of stroke cases it was not possible to study the association separately for these 
two types of cerebrovascular accidents. 
High blood pressure may lead to smooth muscle cell proliferation with 
medial thickening and an increase in the arterial wall content of elastin, collagen 
and glycosarninoglycans (47). They all contribute to the growth of the 
atherosclerotic plaque. There is suggestive evidence that a key role played by 
hypertension might be the triggering of acute plaque disruption caused by effect 
of shear stress on the arterial wall. The narrowing of the arteries can result in 
coronary heart disease and cerebral infarction. Cerebral haemorrhage is caused 
by a rupture of an artery (46). This rupture can be a result of high blood 
pressure. 
In this thesis and in a meta-analysis it was estimated that blood pressure 
reduction could lead to a considerable reduction in cause-specific and total 
mortality (43). We observed that the reduction in cause-specific and total 
mortality is expected to be larger in men than in women. In both men and 
women it is important to prevent and treat high blood pressure. Changes in 
lifestyle factors are recommended as a first step in the management of 
hypertensive persons and also as a way to prevent hypertension (45). The 
following modifications in lifestyle factors are recommended: weight reduction 
if overweight, moderation of alcohol intake, reduction in salt consumption, 
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increased intake of potassium, cessation of smoking as smoking amplifies the 
effect of alcohol on blood pressure and overall cardiovascular health (14-16,48). 
The effect of physical activity on blood pressure is less clear but is also 
recommended because it improves cardiovascular health (14). Physical activity 
is also important in treating obesity (34). All these measures take several months 
to become effective. 
Hypertension can also be treated by medication in which several classes 
of drugs can be recommended (48). In order of proven benefit, based on 
mortality and morbidity studies, they are: (1) diuretics, (2) beta-blockers, (3) 
angiotensin-concerting enzyme inhibitors, (4) calcium antagonists. Diuretic and 
beta-blocker-based therapy have been shown to reduce cardiovascular mortality 
and morbidity. Angiotensm-converting enzyme inhibitors and calcium 
antagonists are effective in lowering blood pressure, but the ability of these 
drugs to reduce cardiovascular events in hypertensive patients has not yet been 
proven in controlled clinical trials. If a decision is made to start pharmacological 
treatment, non-pharmacological treatment remains an important component of 
the overall therapeutic programme. Drug dosages and associated costs may be 
reduced when accompanied by appropriate patient education/counseling in diet 
and weight control (16). Stopping with smoking may also be important because 
otherwise subjects may not receive the full degree of protection against 
cardiovascular diseases from the drugs (49). 
Long-term and large clinical trials using antihypertensive treatment have 
included both men and women, but have not clearly demonstrated gender 
differences in blood pressure response and outcomes (16). Because the rate of 
cardiovascular events is much lower in middle-aged women than in men, these 
trials had a limited ability to distinguish the degree of benefit from treatments 
between men and women. At the moment data are insufficient to support a 
different approach to the management of hypertension in women. Because of the 
higher death rate in men than in women, more women than men need to be 
treated to achieve the same result with blood-pressure-lowering medication. 
In the CB Heart Project the mortality risk had already increased in persons 
with mild hypertension. These persons need to be followed to monitor their 
blood pressure levels because they are at an increased risk, compared with 
normotensive persons of developing definite high blood pressure and of 
experiencing non-fatal and fatal cardiovascular events (48). In persons with 
initial high blood pressure repeated blood pressure measurements will show 
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whether or not initial elevations persist and require close attention, or whether 
they have returned to normal and need only periodic remeasurement. 
The goal of treating persons with high blood pressure is to prevent 
cardiovascular morbidity and mortality. This should be accomplished by 
reaching and maintaining a systolic blood pressure below 140 mmHg and a 
diastolic blood pressure below 90 mmHg (48). In addition to blood pressure 
measurement, the presence of other cardiovascular risk factors should be 
evaluated because the risk of high blood pressure is substantially modified by 
the presence of other risk factors. These risk factors can be divided in non-
modifiable and modifiable risk factors. The non-modifiable factors are: gender 
(men), family history of premature cardiovascular diseases, previous 
cardiovascular events and diabetes mellitus. The modifiable factors are: smoking, 
hypercholesterolemia (6.5 mmol/1 or higher), reduced high-density lipoprotein 
cholesterol (<0.9 mmol/1) and a Quetelet index of 30 kg/m2 or higher. Besides 
blood pressure also the other modifiable cardiovascular risk factors should be 
controlled. 
The current practice for the treatment of hypertension in the Netherlands 
is as follows: 
- Blood pressure must be measured at least three times over a period of 1 to 3 
months to establish increased diastolic blood pressure of 105 mmHg or above 
and must be measured twice each time (14). 
- Blood pressure must be measured at least five times over a period of 3 to 6 
months to establish increased diastolic blood pressure between 95 to 104 mmHg. 
and must be measured twice each time. 
- If diastolic blood pressure is 105 mmHg or above, both pharmacological and 
non-pharmacological treatment is needed. 
- If diastolic blood pressure is between 100-104 mmHg, non-pharmacological 
treatment is needed. 
- Pharmacological treatment should be considered when two or more other 
cardiovascular risk factors are present. 
- If diastolic blood pressure is between 95 to 99 mmHg, only non-
pharmacological treatment is needed. 
In the CB Heart Project it was observed that pharmacological treatment 
was more common in women than in men. This may simply be a consequence 
of the fact that women more often consult a physician for various reasons and 
therefore may have their blood pressure checked more often (50). Also, in other 
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countries it was observed that more women were treated for hypertension than 
men (51,52). In men the mortality rate and the population-attributable risks are 
high; a reduction in blood pressure results in a considerable mortality reduction. 
Therefore treatment of high blood pressure is of great importance for men. Men 
do not consult a physician very often and therefore means need to be explored 
to trace men with high blood pressure. Occupational health services providing 
(periodic) physical examinations or physicians who do check-ups at centres for 
blood donation offer possibilities. An advantage of these periodic checks is that 
the blood pressure levels can be monitored. 
Conclusion 
In our study it was shown that within a study period in which blood pressure 
measurements were taken continuously the levels remained about the same, 
while the average blood pressure level decreased in every following study 
period. This indicates that reliable trends in blood pressure can only be 
established when continuous standardized blood pressure measurements over a 
long time period are available. 
Weight reduction, salt and alcohol restriction, and increased potassium 
intake, are the most effective approaches to the primary prevention of 
hypertension. These measures also lower blood pressure in patients with mild 
hypertension. These dietary recommendations are in agreement with the 
Guidelines for a Healthy Diet of the Netherlands Nutrition Council. The 
evidence for dietary magnesium is less convincing. Because the available data 
are insufficient more placebo-controlled studies should be conducted to estimate 
the effect of magnesium on blood pressure. Calcium does not seem to have a to 
have a blood-pressure-lowering effect. The effect of physical activity on blood 
pressure is less clear and requires more well-designed studies before it can be 
confidently recommended for prevention and treatment of hypertension. 
Blood pressure is strongly associated with cardiovascular and total 
mortality in both men and women. It was estimated that a downward shift in 
blood pressure will result in a considerable reduction in cardiovascular and total 
mortality in both men and women, greater in men than in women. These 
potential benefits make primary prevention of hypertension an important goal. 
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High blood pressure along with smoking and elevated serum cholesterol is one 
of the major risk factors for cardiovascular diseases and the most important risk 
factor for cerebrovascular accidents. The level of blood pressure in the 
population is directly related to the burden of cardiovascular diseases in the 
society. From a public-health point of view data are needed on levels and trends 
in systolic and diastolic blood pressure, and on the prevalence and treatment of 
hypertension, in the population. It is also important to know what percentage of 
mortality from coronary heart disease, cerebrovascular accident, cardiovascular 
diseases and all causes is due to elevated blood pressure and what the potential 
effect of blood pressure lowering on cause-specific and total mortality could be 
in the population. For primary prevention of hypertension and non-
pharmacological treatment it is important to determine the factors which 
influence blood pressure. 
Using data of the Consultation Bureau Project (CB Heart Project) and the 
Coronary Heart Disease Risk Factor Project (RIFOH Project), the trends in 
blood pressure, as well as the prevalence and treatment of hypertension, were 
studied in about 30,000 men and women aged 37-43 years during the period 
1974-1980 and in about 80,000 men aged 33-37 years during the period 1981-
1986 (Chapter 2). An increase in this average systolic blood pressure of 2 
mmHg in men between 1974-1980 was followed by an insignificant change 
between 1981-1986. Average diastolic blood pressure increased by 4 mmHg 
between 1974-1980 but decreased by the same amount between 1981-1986. 
Between 1974-1980 average systolic blood pressure did not change in women 
while average diastolic blood pressure increased by 2 mmHg during that period. 
The prevalence of hypertension in men aged 37-43 years increased from 13% 
in 1974 to 18% in 1980; the percentage of hypertensive women aged 37-43 
years was 9% in 1974 and did not change between 1974-1980. In 1981 the 
prevalence of hypertension was 10% in men aged 33-37 years and did not 
change between 1981-1986.Treatment of hypertensive men increased from 8% 
in 1974 to 21% in 1980, and from 9% in 1981 to 13% in 1986. The percentage 
of treated hypertensive women was 28% and did not change between 1974 and 
1980. 
Data from the Cardiovascular Risk Factors Monitoring Project (CRFM 
Project) collected between 1987 and 1991 were used to study levels and trends 
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in systolic and diastolic blood pressure, and prevalence and treatment of 
hypertension in about 36,000 men and women aged 20-59 years (Chapter 3). 
Seasonal variation in blood pressure was also studied. In summer blood pressure 
in both men and women was about 1 to 2 mmHg lower than in the other 
seasons. In 1987 systolic blood pressure was 124 mmHg in men and 117 mmHg 
in women. Diastolic blood pressure was 78 mmHg in men and 75 mmHg in 
women. The prevalence of hypertension was 8% in both men and women. 
Between 1987 and 1991 systolic blood pressure decreased slightly while 
diastolic blood pressure increased slightly. The prevalence of hypertension did 
not change in this period. The percentage of hypertensive men treated decreased 
from 44% in 1987 to 34% in 1991, and that of hypertensive women treated from 
60% to 49%. 
Data from the Cardiovascular Risk Factors Monitoring Project were used 
to investigate the association between alcohol consumption and blood pressure, 
and the level at which blood pressure starts to increase (Chapter 4). We also 
assessed effect modification and confounding of this association by age, 
smoking, degree of obesity, coffee consumption, physical activity during leisure 
time and educational level. After adjustment for age, body mass index and 
smoking, we found that in men systolic and diastolic blood pressure increased 
by 0.9 and 0.6 mmHg per drink per day, respectively. In women, systolic and 
diastolic blood pressure were 2 and 1 mmHg, respectively, higher in those who 
consumed two or more glasses/day compared with non-drinkers. We observed 
a stronger association between alcohol and blood pressure in older men 
compared with younger men, and in male and female smokers compared with 
non-smokers. 
The data from the Cardiovascular Risk Factors Monitoring Project were 
also used to study the relation between blood pressure and dietary potassium, 
magnesium and calcium, and the combined effect of these minerals on blood 
pressure (Chapter 5). After adjustment for age, body mass index, alcohol and 
energy intake an inverse association was observed between blood pressure and 
dietary potassium and magnesium in both men and women. Dietary calcium was 
inversely related to systolic blood pressure in women and with diastolic blood 
pressure in both men and women. Men and women consuming a diet high in 
potassium, magnesium and calcium had about 2 mmHg lower systolic and 
diastolic blood pressure levels compared to men and women consuming a diet 
low in these minerals. 
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In the CB Heart Project the association between blood pressure and 
mortality from all causes, coronary heart disease, cerebrovascular accident and 
cardiovascular diseases was studied in 50,000 men and women aged 30-54 years 
at baseline (Chapter 6). Average follow-up time was 12 years. Interaction by 
obesity and smoking was analyzed as well. Systolic blood pressure levels of 
>140 mmHg or diastolic blood pressure levels of >90 mmHg were associated 
with increased cardiovascular and total mortality in both sexes. In men both the 
absolute and relative risks were higher than in women. In men the population-
attributable risks were 18% for total mortality, 28% for coronary heart disease 
and 58% for cerebrovascular accident mortality. For women these percentages 
were 7%, 19% and 27%, respectively. No significant interactions were observed 
for obesity and smoking. It was estimated that a 6-mmHg decrease in diastolic 
blood pressure would result in a mortality reduction of about 41% for CVD and 
28% for all causes in men, and 29% and 12%, respectively, in women. 
We concluded that within a study period in which daily blood pressure 
measurements were available, the levels remained about the same while the 
average blood pressure level decreased in every following study period (Chapter 
7). This indicates that reliable trends in blood pressure can only be established 
when continuous standardized blood pressure measurements over a long time 
period are available. Weight reduction, salt and alcohol restriction, and increased 
potassium intake, are the most effective approaches to the primary prevention 
of hypertension. The evidence for dietary magnesium is less convincing. 
Calcium does not seem to have a blood-pressure-lowering effect. Also the effect 
of physical activity on blood pressure is not yet clear. Blood pressure is strongly 
associated with cardiovascular and total mortality in both men and women. It 
was estimated that a downward shift in blood pressure through preventive 
measures results in a considerable reduction in cardiovascular and total mortality 
in both men and women. This reduction was greater in men than in women. 
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Verhoogde bloeddruk is samen met roken en een verhoogd cholesterolgehalte 
een van de belangrijkste risicofactoren voor hart- en vaatziekten. De sterkste 
relatie wordt gevonden voor cerebrovasculaire ziekten. Het niveau van de 
bloeddruk is gerelateerd aan het voorkomen van hart- en vaatziekten in de 
bevolking. Vanuit het oogpunt van de volksgezondheid zijn gegevens nodig over 
de niveaus en trends in bloeddruk en over de prevalentie en behandeling van 
hypertensie. Het is van belang om te weten welk percentage van de sterfte aan 
coronaire hartziekten, cerebrovasculaire ziekten, cardiovasculaire ziekten en 
totale sterfte het gevolg is van een te hoge bloeddruk en wat het mogelijke 
effect is van bloeddrukverlaging in de bevolking op de totale en oorzaak-
specifieke sterfte. Voor preventie en voor niet-medicamenteuze behandeling van 
hypertensie is informatie gewenst over factoren die de bloeddruk beïnvloeden. 
In dit proefschrift worden trends in bloeddruk, prevalentie en behandeling 
van hypertensie beschreven aan de hand van gegevens van een drietal 
langlopende projecten. Van circa 30,000 mannen en vrouwen van 37-43 jaar zijn 
gegevens verzameld in het kader van het Consultatiebureau Project Hart- en 
Vaatziekten tussen 1974-1980. Circa 80,000 mannen van 33-37 jaar zijn 
onderzocht in het kader van het Risicofactoren Onderzoek Hart- en Vaatziekten 
tussen 1981-1986 (Hoofdstuk 2). Tussen 1974-1980 steeg bij mannen de 
gemiddelde systolische bloeddruk met 2 mmHg en werd dit gevolgd door een 
niet-significante verandering tussen 1981 en 1986. De gemiddelde diastolische 
bloeddruk steeg 4 mmHg tussen 1974 en 1980 en daalde met 4 mmHg tussen 
1981 en 1986. Tussen 1974 en 1980 veranderde de gemiddelde systolische 
bloeddruk niet maar de diastolische bloeddruk steeg met 2 mmHg in die periode. 
Het percentage hypertensieve mannen steeg van 13% in 1974 tot 18% in 1980 
en het percentage hypertensieve vrouwen was 9% en bleef constant tussen 1974 
en 1980. Het percentage hypertensieve mannen bedroeg 10% tussen 1981 en 
1986. Behandeling van hypertensieve mannen steeg van 8% in 1974 tot 21% in 
1980 en van 9% in 1981 tot 13% in 1986. Van de hypertensieve vrouwen werd 
tussen 1974 en 1980 28% behandeld. 
Tussen 1987 en 1991 zijn ongeveer 36,000 mannen en vrouwen van 20-59 
jaar onderzocht in het kader van het Peilstationsproject Hart- en Vaatziekten. 
Gegevens van dit project werden gebruikt om de trends in bloeddruk, 
prevalentie en behandeling van hypertensie en de invloed van het seizoen op de 
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bloeddruk te bestuderen (Hoofdstuk 3). In de zomer was de bloeddruk 1 ä 2 
mmHg lager dan in de andere seizoenen. In 1987 was de gemiddelde systolische 
en diastolische bloeddruk bij mannen 124 en 78 mmHg en bij vrouwen 117 en 
75 mmHg. De prevalentie van hypertensie was in 1987 bij mannen en vrouwen 
8%. Bij zowel mannen als vrouwen werd er een geringe daling van de systoli-
sche bloeddruk waargenomen en een geringe stijging van de diastolische 
bloeddruk. Het percentage hypertensieve mannen en vrouwen veranderde niet 
tussen 1987 en 1991. Het percentage behandelde hypertensieven daalde in de 
periode 1987-1991 van 44% tot 34% bij mannen en van 60 tot 49% bij 
vrouwen. 
De gegevens van het Peilstationsproject Hart- en Vaatziekten werden ook 
gebruikt om de associatie tussen alcoholconsumptie en bloeddruk te bestuderen 
en na te gaan bij welk niveau van de alcoholconsumptie de bloeddruk begint te 
stijgen (Hoofdstuk 4). Daarnaast is de invloed van leeftijd, roken, Quetelet 
Index, koffieconsumptie, lichamelijke activiteit en opleiding op de associatie 
bestudeerd. Na correctie voor leeftijd, Quetelet Index en roken werd bij mannen 
een stijging van de systolische en diastolische bloeddruk van 0.9 en 0.6 mmHg 
per glas per dag waargenomen. Bij vrouwen was de systolische en diastolische 
bloeddruk respectievelijk 2 en 1 mmHg hoger bij een alcoholconsumptie van 2 
of meer glazen per dag ten opzichte van de met-drinkers. Verder werd 
waargenomen dat de relatie tussen alcoholconsumptie en systolische bloeddruk 
sterker is bij oudere vergeleken met jongere mannen. Voor zowel mannen als 
vrouwen werd waargenomen dat de relatie tussen alcoholconsumptie en 
systolische en diastolische bloeddruk sterker is bij rokers dan niet-rokers. 
Het verband tussen de inname van kalium, magnesium en calcium en 
bloeddruk en het gecombineerde effect van deze drie mineralen op de bloeddruk 
werd eveneens bestudeerd in het Peilstationsproject Hart- en Vaatziekten 
(Hoofdstuk 5). Na correctie yoor leeftijd, Quetelet index, inname van alcohol en 
energie werd bij zowel mannen als vrouwen een invers verband waargenomen 
tussen bloeddruk en de inname van kalium en magnesium. De inname van 
calcium was negatief geassocieerd met de systolische bloeddruk bij vrouwen en 
met de systolische en diastolische bloeddruk bij zowel mannen als vrouwen. 
Mannen en vrouwen die een voeding gebruiken die rijk is aan kalium, 
magnesium en calcium hebben een systolische en diastolische bloeddruk die 2 
mmHg lager is dan bij personen die een voeding gebruiken die arm is aan deze 
mineralen. 
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In het Consultatiebureauproject Hart- en Vaatziekten werd de associatie 
tussen bloeddruk en sterfte aan coronaire hartziekten, cerebrovasculaire ziekten, 
cardiovasculaire ziekten en totale sterfte bestudeerd bij 50,000 mannen en 
vrouwen van 30-54 jaar (Hoofdstuk 6). De gemiddelde follow-up was 12 jaar. 
Ook werd de invloed van Quetelet index en roken op deze relaties bestudeerd. 
Een systolische bloeddruk >140 mmHg en/of een diastolische bloeddruk >90 
mmHg waren geassocieerd met de totale en cardiovasculaire sterfte bij zowel 
mannen als vrouwen. Bij mannen was 18% van de totale sterfte, 28% van de 
sterfte aan coronaire hartziekten en 58% van de sterfte aan cerebrovasculaire 
ziekten het gevolg van een te hoge bloeddruk. Bij vrouwen waren deze 
percentages 7%, 19% en 27%. Roken en Quetelet index hadden geen invloed op 
deze associaties. Een daling van de diastolische bloeddruk met 6 mmHg kan 
resulteren in een daling van 41% in cardiovasculaire sterfte en 28% in totale 
sterfte bij mannen en van 29% in cardiovasculaire sterfte en 12% in totale sterfte 
bij vrouwen. 
Wij concludeerden dat de gemiddelde bloeddruk nauwelijks is veranderd 
in elk van de drie studie periodes terwijl het bloeddruk niveau lager was in elke 
volgende studie periode (Hoofdstuk 7). Dit geeft aan dat betrouwbare trends 
alleen gebaseerd kunnen worden op continue gestandaardiseerde 
bloeddrukmetingen over een lange periode. Gewichtsvermindering, beperking 
van alcohol- en zoutinname en een verhoogde inname van kalium zijn de 
belangrijkste maatregelen die genomen kunnen worden om hypertensie te 
voorkomen. Het blijkt dat calcium geen bloeddrukverlagende werking heeft en 
dat het effect van magnesium op de bloeddruk nog onduidelijk is. Definitieve 
uitspraken over het effect van lichamelijke activiteit op de bloeddruk kunnen 
nog niet gedaan worden. Bloeddruk is sterk gerelateerd aan zowel totale en 
cardiovasculaire sterfte bij mannen en vrouwen. Een verlaging van de bloeddruk 
door preventieve maatregelen resulteert in een daling in totale en 
cardiovasculaire sterfte bij mannen en vrouwen. Deze daling is bij mannen 
groter dan bij vrouwen. 
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